Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:aminobenzoic acid
go back to main search page
Accession:CHEBI:22495 term browser browse the term
Synonyms:related_synonym: Aminobenzoesaeure;   Formula=C7H7NO2
 cyclic_relationship: is_conjugate_acid_of CHEBI:22494


show annotations for term's descendants           Sort by:
3-aminobenzoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gpd1 glycerol-3-phosphate dehydrogenase 1 multiple interactions ISO [INS1 protein co-treated with 3-aminobenzoic acid] results in increased activity of GPD1 protein CTD PMID:2523799 NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529 		JBrowse link
G Ins1 insulin 1 multiple interactions ISO [INS1 protein co-treated with 3-aminobenzoic acid] results in increased activity of GPD1 protein CTD PMID:2523799 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536 		JBrowse link
4-aminobenzoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Creb1 cAMP responsive element binding protein 1 affects expression ISO 4-Aminobenzoic Acid affects the expression of CREB1 mRNA CTD PMID:20385217 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816 		JBrowse link
G Il2 interleukin 2 increases expression ISO 4-Aminobenzoic Acid results in increased expression of IL2 protein CTD PMID:22381623 NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566 		JBrowse link
G Il4i1 interleukin 4 induced 1 decreases activity ISO 4-Aminobenzoic Acid results in decreased activity of IL4I1 protein CTD PMID:15383589 NCBI chr 1:95,299,457...95,324,564
Ensembl chr 1:95,295,601...95,324,562 		JBrowse link
G Nat1 N-acetyltransferase 1 multiple interactions
increases metabolic processing
affects acetylation
increases acetylation		 ISO Dehydroepiandrosterone Sulfate inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]; Dehydroepiandrosterone Sulfate promotes the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]; Pentachlorophenol inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]
NAT1 protein results in increased metabolism of 4-Aminobenzoic Acid
NAT1 protein affects the acetylation of 4-Aminobenzoic Acid		 CTD PMID:11470991 PMID:15627487 PMID:15880531 PMID:16003948 PMID:23958860 More... NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520 		JBrowse link
G Nat2 N-acetyltransferase 2 increases acetylation
multiple interactions		 ISO
EXP		 NAT2 protein results in increased acetylation of 4-Aminobenzoic Acid
4-biphenylamine inhibits the reaction [NAT2 protein results in increased acetylation of 4-Aminobenzoic Acid]		 CTD PMID:15627487 PMID:18842621 NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 affects expression ISO 4-Aminobenzoic Acid affects the expression of NFKB1 mRNA CTD PMID:20385217 NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404 		JBrowse link
G Slc22a7 solute carrier family 22 member 7 multiple interactions ISO
EXP		 4-Aminobenzoic Acid promotes the reaction [SLC22A7 protein results in increased export of Orotic Acid] CTD PMID:22981274 NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921 		JBrowse link
G Tnf tumor necrosis factor affects expression ISO 4-Aminobenzoic Acid affects the expression of TNF mRNA CTD PMID:20385217 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
4-aminosalicylic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bmp6 bone morphogenetic protein 6 increases expression ISO Aminosalicylic Acid results in increased expression of BMP6 mRNA CTD PMID:32816093 NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365 		JBrowse link
G Ereg epiregulin increases expression ISO Aminosalicylic Acid results in increased expression of EREG mRNA CTD PMID:32816093 NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062 		JBrowse link
G Il24 interleukin 24 increases expression ISO Aminosalicylic Acid results in increased expression of IL24 mRNA CTD PMID:32816093 NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase increases expression ISO Aminosalicylic Acid results in increased expression of MET mRNA CTD PMID:32816093 NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876 		JBrowse link
G Nat1 N-acetyltransferase 1 increases acetylation ISO NAT1 protein results in increased acetylation of Aminosalicylic Acid CTD PMID:15627487 PMID:16003948 NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520 		JBrowse link
G Nat2 N-acetyltransferase 2 multiple interactions ISO [Peroxynitrous Acid results in decreased activity of NAT2 protein] which results in decreased acetylation of Aminosalicylic Acid CTD PMID:19248797 NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520 		JBrowse link
G Pid1 phosphotyrosine interaction domain containing 1 increases expression ISO Aminosalicylic Acid results in increased expression of PID1 mRNA CTD PMID:32816093 NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO Aminosalicylic Acid results in increased expression of SLC7A11 mRNA CTD PMID:32816093 NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536 		JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression ISO Aminosalicylic Acid results in increased expression of SLPI mRNA CTD PMID:32816093 NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453 		JBrowse link
anthranilic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO anthranilic acid results in increased expression of AKR1B10 mRNA CTD PMID:26198647 NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases activity ISO anthranilic acid analog results in decreased activity of AKR1C1 protein CTD PMID:19007763 NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 decreases abundance ISO IDO1 gene mutant form results in decreased abundance of anthranilic acid CTD PMID:32871117 NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730 		JBrowse link
G Ifng interferon gamma multiple interactions ISO anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein]; anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Il12a interleukin 12A multiple interactions ISO anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903 		JBrowse link
G Il18 interleukin 18 multiple interactions ISO anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887 		JBrowse link
G Ins1 insulin 1 multiple interactions EXP anthranilic acid analog inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] CTD PMID:28625491 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 decreases activity ISO anthranilic acid results in decreased activity of MAP2K1 protein CTD PMID:18393446 NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases activity ISO anthranilic acid results in increased activity of NFE2L2 protein CTD PMID:30114225 NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Ptpn1 protein tyrosine phosphatase, non-receptor type 1 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN1 protein CTD PMID:22864521 NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504 		JBrowse link
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN11 protein CTD PMID:22864521 NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925 		JBrowse link
G Ptpn2 protein tyrosine phosphatase, non-receptor type 2 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN2 protein CTD PMID:22864521 NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627 		JBrowse link
G Ptpn6 protein tyrosine phosphatase, non-receptor type 6 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN6 protein CTD PMID:22864521 NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984 		JBrowse link
G Ptpn9 protein tyrosine phosphatase, non-receptor type 9 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN9 protein CTD PMID:22864521 NCBI chr 8:57,391,290...57,472,352
Ensembl chr 8:57,391,259...57,470,952 		JBrowse link
G Tdo2 tryptophan 2,3-dioxygenase decreases abundance ISO TDO2 gene mutant form results in decreased abundance of anthranilic acid CTD PMID:32871117 NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511 		JBrowse link
butamben term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor affects binding EXP butamben binds to AR protein CTD PMID:14565775 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Med1 mediator complex subunit 1 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to MED1 protein]; butamben promotes the reaction [NR1I2.S protein binds to MED1 protein] CTD PMID:12198127 NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299 		JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to NCOA1 protein]; butamben promotes the reaction [NR1I2.S protein binds to NCOA1 protein] CTD PMID:12198127 NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to NCOA2 protein] CTD PMID:12198127 NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451 		JBrowse link
G Ncoa3 nuclear receptor coactivator 3 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to NCOA3 protein] CTD PMID:12198127 NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594 		JBrowse link
Calcimycin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions		 ISO Calcimycin results in increased phosphorylation of AKT1 protein
Cyclosporine inhibits the reaction [Calcimycin results in increased phosphorylation of AKT1 protein]		 CTD PMID:10679475 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions
increases activity
increases expression		 ISO
EXP		 1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] affects the localization of ALOX5 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of ALOX5 protein; [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Platelet Activating Factor]; bisindolylmaleimide I inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]; bolinaquinone inhibits the reaction [Calcimycin results in increased activity of ALOX5 protein]; Calcimycin results in increased activity of and results in increased localization of ALOX5 protein; Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein; Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; SB 203580 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]; tert-Butyl Alcohol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; U 0126 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]
Calcimycin results in increased expression of ALOX5 mRNA; Calcimycin results in increased expression of ALOX5 protein
[[A 78773 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [[CMI 392 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [[zileuton co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene B4; [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene C4; [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Leukotriene B4]; Calcimycin results in increased activity of and results in increased localization of ALOX5 protein; Calcimycin results in increased localization of and results in increased activity of ALOX5 protein; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA]; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]		 CTD PMID:7665580 PMID:8387780 PMID:9445378 PMID:10779545 PMID:11529688 More... NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743 		JBrowse link
G Ano1 anoctamin 1 decreases activity ISO Calcimycin results in decreased activity of ANO1 protein CTD PMID:24478309 NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069 		JBrowse link
G Apoe apolipoprotein E decreases response to substance ISO APOE gene mutant form results in decreased susceptibility to Calcimycin CTD PMID:11397713 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression		 ISO Calcimycin affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of BAX mRNA]
Calcimycin results in increased expression of BAX mRNA		 CTD PMID:26419736 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [semaglutide inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]] CTD PMID:36075570 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bcl2l1 Bcl2-like 1 decreases response to substance EXP BCL2L1 gene mutant form results in decreased susceptibility to Calcimycin CTD PMID:10970895 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP2 mRNA] CTD PMID:21331654 NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397 		JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP6 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP6 mRNA] CTD PMID:21331654 NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365 		JBrowse link
G Casp1 caspase 1 multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased cleavage of CASP1 protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein] CTD PMID:21515303 PMID:22322153 PMID:23535185 NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383 		JBrowse link
G Casp3 caspase 3 increases expression
multiple interactions		 EXP
ISO		 Calcimycin results in increased expression of CASP3 protein
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [semaglutide inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP3 protein]]; Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein]		 CTD PMID:16787641 PMID:19837105 PMID:20020783 PMID:36075570 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp7 caspase 7 increases activity ISO Calcimycin results in increased activity of CASP7 protein CTD PMID:19139269 NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729 		JBrowse link
G Casp8 caspase 8 increases activity ISO Calcimycin results in increased activity of CASP8 protein CTD PMID:25410152 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Casp9 caspase 9 increases activity ISO Calcimycin results in increased activity of CASP9 protein CTD PMID:25410152 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL11 mRNA; CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL11 mRNA]; IL5 protein promotes the reaction [CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] CTD PMID:12797483 PMID:21331654 NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression		 ISO Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of CCL2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL2 mRNA
Calcimycin results in increased expression of CCL2 mRNA		 CTD PMID:8764118 PMID:18799549 PMID:30254419 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of CCL4 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of CCL4 mRNA]		 CTD PMID:25451590 NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO
EXP		 CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]; IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]
[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA]; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein]; Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]; Masoprocol inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]		 CTD PMID:12797483 PMID:18083043 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of CCL7 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of CCL7 mRNA]		 CTD PMID:25451590 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303 		JBrowse link
G Cd40 CD40 molecule multiple interactions ISO Apigenin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; Luteolin inhibits the reaction [Calcimycin results in increased expression of CD40 protein]; Quercetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] CTD PMID:16601352 NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534 		JBrowse link
G Cd69 Cd69 molecule multiple interactions
increases expression		 ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein]
Calcimycin results in increased expression of CD69 protein		 CTD PMID:23941771 PMID:25410152 NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO Calcimycin promotes the reaction [Cadmium Chloride results in increased cleavage of CDH1 protein] CTD PMID:18791180 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
increases secretion
increases expression		 ISO
EXP		 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]; Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]
Calcimycin results in increased secretion of CSF2 protein
Luteolin inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA]		 CTD PMID:1376361 PMID:9685678 PMID:17950587 NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199 		JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of AXUD1 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA]		 CTD PMID:25451590 NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO Calcimycin results in increased expression of CXCL1 mRNA CTD PMID:8764118 NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases activity
increases expression
multiple interactions		 ISO Calcimycin results in increased activity of DDIT3 protein
Calcimycin results in increased expression of DDIT3 mRNA; Calcimycin results in increased expression of DDIT3 protein
parthenolide promotes the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; RELA protein inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]		 CTD PMID:11145585 PMID:11360202 PMID:19139269 PMID:19428936 PMID:27064126 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of DUSP1 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP1 mRNA]		 CTD PMID:25451590 NCBI chr10:16,680,478...16,683,275 JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of DUSP6 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP6 mRNA]		 CTD PMID:25451590 NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185 		JBrowse link
G Edn1 endothelin 1 multiple interactions EXP [EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides; NOS3 protein affects the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides]; Polyphenols inhibits the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides] CTD PMID:20977430 NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885 		JBrowse link
G Egr1 early growth response 1 increases expression ISO Calcimycin results in increased expression of EGR1 mRNA CTD PMID:8764118 NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766 		JBrowse link
G Egr2 early growth response 2 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of EGR2 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of EGR2 mRNA]		 CTD PMID:25451590 NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562 		JBrowse link
G Egr3 early growth response 3 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of EGR3 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of EGR3 mRNA]		 CTD PMID:25451590 NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A increases phosphorylation
multiple interactions		 ISO Calcimycin results in increased phosphorylation of EIF2A protein
Quercetin inhibits the reaction [Calcimycin results in increased phosphorylation of EIF2A protein]		 CTD PMID:19428936 NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases expression ISO Calcimycin results in increased expression of ERN1 protein CTD PMID:19139269 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FAS mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FAS mRNA] CTD PMID:21331654 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591 		JBrowse link
G Faslg Fas ligand affects expression ISO Calcimycin affects the expression of FASL protein
Calcimycin affects the expression of FASLG protein		 CTD PMID:25410152 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression EXP Calcimycin results in increased expression of FGF1 protein CTD PMID:15264218 NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Flt3 Fms related receptor tyrosine kinase 3 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FLT3 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FLT3 mRNA] CTD PMID:21331654 NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression		 EXP
ISO		 Luteolin inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]		 CTD PMID:1932749 PMID:8764118 PMID:17950587 PMID:25451590 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions		 ISO Calcimycin results in increased expression of FOSB mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of FOSB mRNA]		 CTD PMID:8764118 PMID:25451590 NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465 		JBrowse link
G Gbp3 guanylate binding protein 3 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA] CTD PMID:21331654 NCBI chr 2:231,460,032...231,500,266
Ensembl chr 2:231,486,062...231,493,098 		JBrowse link
G Gch1 GTP cyclohydrolase 1 multiple interactions EXP [2,4-diaminohypoxanthine results in decreased activity of GCH1 protein] which affects the susceptibility to Calcimycin; sepiapterin inhibits the reaction [[2,4-diaminohypoxanthine results in decreased activity of GCH1 protein] which affects the susceptibility to Calcimycin] CTD PMID:12855421 NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698 		JBrowse link
G Gpx4 glutathione peroxidase 4 decreases expression ISO Calcimycin results in decreased expression of GPX4 protein CTD PMID:10432307 NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982 		JBrowse link
G Hdac5 histone deacetylase 5 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [semaglutide inhibits the reaction [Lipopolysaccharides results in increased expression of HDAC5 protein]] CTD PMID:36075570 NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235 		JBrowse link
G Hdc histidine decarboxylase increases expression
multiple interactions		 ISO Calcimycin results in increased expression of HDC mRNA
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein; atractylon inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]; pyeongwee-san extract inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]		 CTD PMID:17191106 PMID:27553716 NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO Calcimycin inhibits the reaction [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein]] CTD PMID:12788823 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hsf1 heat shock transcription factor 1 affects phosphorylation ISO Calcimycin affects the phosphorylation of HSF1 protein CTD PMID:8663271 NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression		 ISO Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 protein]
Calcimycin results in increased expression of HSPA5 mRNA; Calcimycin results in increased expression of HSPA5 protein		 CTD PMID:12147617 PMID:14610226 PMID:18799549 PMID:19139269 PMID:19428936 More... NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Ifng interferon gamma multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein] CTD PMID:1371491 PMID:14994387 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Il12rb1 interleukin 12 receptor subunit beta 1 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL12RB1 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL12RB1 mRNA] CTD PMID:21331654 NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769 		JBrowse link
G Il13 interleukin 13 multiple interactions
increases expression		 ISO
EXP		 [Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL13 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13 mRNA; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL13 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13 mRNA]
shikonin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]
Luteolin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]		 CTD PMID:12789233 PMID:17950587 PMID:21331654 PMID:25451590 NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737 		JBrowse link
G Il13ra1 interleukin 13 receptor subunit alpha 1 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA] CTD PMID:21331654 NCBI chr  X:115,348,822...115,408,682
Ensembl chr  X:115,348,860...115,408,681
Ensembl chr11:115,348,860...115,408,681 		JBrowse link
G Il18r1 interleukin 18 receptor 1 multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL18R1 protein CTD PMID:14994387 NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715 		JBrowse link
G Il1a interleukin 1 alpha increases expression ISO Calcimycin results in increased expression of IL1A mRNA CTD PMID:8435107 NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA; [IL1B protein co-treated with Calcimycin] results in increased activity of PTGS2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL1B protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL1B protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]] CTD PMID:15705740 PMID:17588137 PMID:18958421 PMID:21515303 PMID:22322153 More... NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il2 interleukin 2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein] CTD PMID:1371491 PMID:23941771 NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566 		JBrowse link
G Il3 interleukin 3 multiple interactions
increases expression		 ISO
EXP		 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]; Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]
Luteolin inhibits the reaction [Calcimycin results in increased expression of IL3 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL3 mRNA]		 CTD PMID:1376361 PMID:17950587 NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066 		JBrowse link
G Il4 interleukin 4 multiple interactions
increases expression
affects response to substance		 ISO
EXP		 [Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL4 protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA]; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL4 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; hispidulin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 mRNA]; Houttuynia cordata extract inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]; IL4 protein inhibits the reaction [Calcimycin results in increased metabolism of Leukotriene B4]; IL4 protein promotes the reaction [Calcimycin results in increased metabolism of Hydroxyeicosatetraenoic Acids metabolite]; kaempferol inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4]; Quercetin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]
Luteolin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]
IL4 protein affects the susceptibility to Calcimycin		 CTD PMID:1371491 PMID:11861792 PMID:12789233 PMID:16601352 PMID:17950587 More... NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750 		JBrowse link
G Il5 interleukin 5 multiple interactions
increases expression		 ISO [Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; Houttuynia cordata extract inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]; IL5 protein promotes the reaction [CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]; IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]; kaempferol inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein] CTD PMID:1371491 PMID:12789233 PMID:12797483 PMID:18325701 NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases secretion
increases expression		 ISO 3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxanthyletin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; [Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL6 protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [semaglutide inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein; Calcimycin inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; fraxetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; isopraeroside IV inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; levistolide A inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]
Calcimycin results in increased secretion of IL6 protein
Calcimycin results in increased expression of IL6 mRNA		 CTD PMID:11238657 PMID:12789233 PMID:17191106 PMID:17588137 PMID:18958421 More... NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Inhbc inhibin subunit beta C multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of INHBC mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of INHBC mRNA] CTD PMID:21331654 NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630 		JBrowse link
G Irf8 interferon regulatory factor 8 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IRF8 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IRF8 mRNA] CTD PMID:21331654 NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829 		JBrowse link
G Itga2 integrin subunit alpha 2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGA2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGA2 mRNA] CTD PMID:21331654 NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481 		JBrowse link
G Itgam integrin subunit alpha M increases expression
multiple interactions		 ISO Calcimycin results in increased expression of ITGAM protein
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGAM mRNA; Dexamethasone analog inhibits the reaction [Calcimycin results in increased expression of ITGAM protein]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGAM mRNA]; Resveratrol analog inhibits the reaction [Calcimycin results in increased expression of ITGAM protein]		 CTD PMID:8094364 PMID:18776917 PMID:21331654 NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Itgb2 integrin subunit beta 2 increases expression ISO Calcimycin results in increased expression of ITGB2 protein CTD PMID:8094364 NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions		 ISO Calcimycin results in increased expression of JUN mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of JUN mRNA]		 CTD PMID:8764118 PMID:25451590 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression		 ISO 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin analog results in increased expression of JUNB mRNA]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin results in increased expression of JUNB mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Calcimycin results in increased expression of JUNB mRNA] CTD PMID:1932749 PMID:8764118 NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035 		JBrowse link
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 decreases expression ISO Calcimycin results in decreased expression of KCNJ5 mRNA CTD PMID:22798349 NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518 		JBrowse link
G Kcnn4 potassium calcium-activated channel subfamily N member 4 increases activity ISO Calcimycin results in increased activity of KCNN4 protein CTD PMID:17699636 NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340 		JBrowse link
G Map3k8 mitogen-activated protein kinase kinase kinase 8 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of MAP3K8 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of MAP3K8 mRNA]		 CTD PMID:25451590 NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation		 ISO
EXP		 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein; Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein; resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein]
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Calcimycin results in increased activity of MAPK1 protein]; AG 1879 inhibits the reaction [Calcimycin results in increased activity of MAPK1 protein]; Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]; Gadolinium inhibits the reaction [Calcimycin results in increased phosphorylation of MAPK1 protein]; W 7 inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]		 CTD PMID:11914123 PMID:18776917 PMID:19416633 PMID:19782052 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation		 ISO
EXP		 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein; Calcimycin results in increased phosphorylation of and results in increased activity of MAPK3 protein; resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein]
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Calcimycin results in increased activity of MAPK3 protein]; AG 1879 inhibits the reaction [Calcimycin results in increased activity of MAPK3 protein]; Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]; Gadolinium inhibits the reaction [Calcimycin results in increased phosphorylation of MAPK3 protein]; W 7 inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]		 CTD PMID:11914123 PMID:18776917 PMID:19416633 PMID:19782052 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MAPK8 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MAPK8 mRNA] CTD PMID:21331654 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Mpo myeloperoxidase increases secretion
multiple interactions
affects activity		 ISO
EXP		 Calcimycin results in increased secretion of MPO protein
carvedilol inhibits the reaction [Calcimycin results in increased secretion of MPO protein]
Calcimycin affects the activity of MPO protein		 CTD PMID:18475545 PMID:18987595 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819 		JBrowse link
G Ms4a2 membrane spanning 4-domains A2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MS4A2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MS4A2 mRNA] CTD PMID:21331654 NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310 		JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO Calcimycin promotes the reaction [[Hydrogen Peroxide co-treated with Vanadates] results in increased expression of MSR1 mRNA alternative form] CTD PMID:10837497 NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676 		JBrowse link
G Mt1 metallothionein 1 increases expression EXP Calcimycin results in increased expression of MT1A mRNA CTD PMID:8128501 NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
Ensembl chr  X:10,826,032...10,827,049 		JBrowse link
G Mt2A metallothionein 2A multiple interactions
increases expression		 ISO shikonin inhibits the reaction [Calcimycin results in increased expression of MT2 mRNA] CTD PMID:25451590 NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784 		JBrowse link
G Naga alpha-N-acetylgalactosaminidase affects activity EXP Calcimycin affects the activity of NAGA protein CTD PMID:18475545 NCBI chr 7:113,846,358...113,855,430
Ensembl chr 7:113,846,374...113,855,315 		JBrowse link
G Nfatc1 nuclear factor of activated T-cells 1 multiple interactions
affects localization		 ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of NFATC1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [Cyclosporine results in decreased expression of NFATC1 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of NFATC1 protein; NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]
Calcimycin affects the localization of NFATC1 protein		 CTD PMID:21603612 PMID:24244623 PMID:27246103 NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028 		JBrowse link
G Nfatc2 nuclear factor of activated T-cells 2 increases activity
multiple interactions		 ISO Calcimycin results in increased activity of NFATC2 protein
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein; Cyclosporine inhibits the reaction [Calcimycin results in increased activity of NFATC2 protein]; fisetin inhibits the reaction [Calcimycin results in increased activity of NFATC2 protein]; NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein]		 CTD PMID:12789233 PMID:21603612 PMID:23941771 NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:157,198,872...157,328,325 		JBrowse link
G Nfatc3 nuclear factor of activated T-cells 3 multiple interactions ISO NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150 		JBrowse link
G Nfatc4 nuclear factor of activated T-cells 4 multiple interactions ISO NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [semaglutide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein] CTD PMID:17588137 PMID:19416633 PMID:19665545 PMID:21515303 PMID:22322153 More... NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Nfkbid NFKB inhibitor delta increases expression
multiple interactions		 ISO Calcimycin results in increased expression of NFKBID mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBID mRNA]		 CTD PMID:25451590 NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447 		JBrowse link
G Nfkbiz NFKB inhibitor zeta increases expression
multiple interactions		 ISO Calcimycin results in increased expression of NFKBIZ mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBIZ mRNA]		 CTD PMID:25451590 NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723 		JBrowse link
G Ngf nerve growth factor multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [Cyclosporine results in increased expression of NGF protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased expression of NGF protein CTD PMID:24244623 NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Calcimycin] CTD PMID:11498454 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Nos3 nitric oxide synthase 3 increases activity
increases expression
multiple interactions		 EXP
ISO		 Calcimycin results in increased activity of NOS3 protein
Calcimycin results in increased expression of NOS3 mRNA
Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA]
[Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides; Nitroglycerin promotes the reaction [[Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides]; NOS3 protein affects the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides]		 CTD PMID:10625313 PMID:11796706 PMID:19837105 PMID:20020783 PMID:20977430 NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166 		JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 multiple interactions
increases expression		 ISO NR4A1 mRNA promotes the reaction [Calcimycin results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A1 mRNA] CTD PMID:25451590 NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297 		JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of NR4A2 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A2 mRNA]		 CTD PMID:25451590 NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877 		JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of NR4A3 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A3 mRNA]		 CTD PMID:25451590 NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733 		JBrowse link
G Ntf3 neurotrophin 3 increases expression EXP Calcimycin results in increased expression of NTF3 protein CTD PMID:19854260 NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596 		JBrowse link
G Otc ornithine transcarbamylase multiple interactions EXP [Calcimycin co-treated with Cyclosporine] results in decreased activity of OTC protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]]; didemnins inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]] CTD PMID:3097147 NCBI chr  X:12,453,834...12,529,954
Ensembl chr  X:12,453,834...12,566,918 		JBrowse link
G Padi4 peptidyl arginine deiminase 4 multiple interactions ISO Calcimycin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of PADI4 protein] CTD PMID:29425503 NCBI chr 5:153,041,351...153,074,412
Ensembl chr 5:153,041,352...153,074,362 		JBrowse link
G Plk3 polo-like kinase 3 increases expression
multiple interactions		 ISO Calcimycin results in increased expression of PLK3 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of PLK3 mRNA]		 CTD PMID:25451590 NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression
multiple interactions		 ISO Calcimycin results in increased expression of PPP1R15A mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of PPP1R15A mRNA]		 CTD PMID:25451590 NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 increases phosphorylation ISO Calcimycin results in increased phosphorylation of PRKAA1 protein CTD PMID:28298333 NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978 		JBrowse link
G Prkcd protein kinase C, delta multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein] CTD PMID:23941771 NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352 		JBrowse link
G Prl prolactin multiple interactions EXP [Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]] CTD PMID:3097147 NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression		 ISO [IL1B protein co-treated with Calcimycin] results in increased activity of PTGS2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein; Calcimycin promotes the reaction [[Hydrogen Peroxide co-treated with Vanadates] results in increased expression of PTGS2 mRNA alternative form]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]
Calcimycin results in increased expression of PTGS2 mRNA; Calcimycin results in increased expression of PTGS2 protein
shikonin inhibits the reaction [Calcimycin results in increased expression of PTGS2 mRNA]		 CTD PMID:9013627 PMID:10837497 PMID:15705740 PMID:19416633 PMID:19782052 More... NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Ptprc protein tyrosine phosphatase, receptor type, C affects response to substance
increases response to substance
increases expression		 ISO PTPRC protein affects the susceptibility to Calcimycin
PTPRC protein results in increased susceptibility to Calcimycin
Calcimycin results in increased expression of PTPRC protein		 CTD PMID:25410152 NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692 		JBrowse link
G Pygl glycogen phosphorylase L increases activity
multiple interactions		 EXP Calcimycin results in increased activity of PYGL protein
Calcium deficiency inhibits the reaction [Calcimycin results in increased activity of PYGL protein]		 CTD PMID:6430282 NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310 		JBrowse link
G Rcan1 regulator of calcineurin 1 increases expression ISO Calcimycin results in increased expression of RCAN1 protein CTD PMID:12927602 NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases response to substance
multiple interactions		 ISO RELA gene mutant form results in increased susceptibility to Calcimycin
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [semaglutide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; RELA protein inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]		 CTD PMID:11360202 PMID:17588137 PMID:18958421 PMID:19416633 PMID:19665545 More... NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Sell selectin L decreases expression
multiple interactions		 ISO Calcimycin results in decreased expression of SELL protein
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of SELL mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of SELL mRNA]; resveratrol analog inhibits the reaction [Calcimycin results in decreased expression of SELL protein]		 CTD PMID:18776917 PMID:21331654 NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456 		JBrowse link
G Selp selectin P increases expression ISO Calcimycin results in increased expression of SELP protein CTD PMID:24466103 NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845 		JBrowse link
G Sirt1 sirtuin 1 affects response to substance EXP SIRT1 protein affects the susceptibility to Calcimycin CTD PMID:23422569 NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Sp1 Sp1 transcription factor multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of SP1 protein CTD PMID:24244623 NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961 		JBrowse link
G Sptan1 spectrin, alpha, non-erythrocytic 1 increases cleavage
multiple interactions		 ISO Calcimycin results in increased cleavage of SPTAN1 protein
rosiglitazone inhibits the reaction [Calcimycin results in increased cleavage of SPTAN1 protein]		 CTD PMID:19226370 NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase increases phosphorylation ISO Calcimycin results in increased phosphorylation of SRC protein CTD PMID:19782052 NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476 		JBrowse link
G Tagap T-cell activation RhoGTPase activating protein multiple interactions
increases expression		 ISO shikonin inhibits the reaction [Calcimycin results in increased expression of TAGAP mRNA] CTD PMID:25451590 NCBI chr 1:47,170,725...47,179,705
Ensembl chr 1:47,170,725...47,179,792 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP Calcimycin promotes the reaction [Dexamethasone results in increased activity of TAT protein]; Sphingosine inhibits the reaction [Calcimycin promotes the reaction [Dexamethasone results in increased activity of TAT protein]] CTD PMID:9398635 NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression ISO Calcimycin results in increased expression of TGFB1 mRNA CTD PMID:8148055 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression		 ISO
EXP		 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [semaglutide inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein; Calcimycin results in increased expression of and results in increased secretion of TNF protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Doxycycline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; fraxetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; hispidulin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; isopraeroside IV inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; prolinedithiocarbamate inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]
Calcimycin results in increased expression of TNF mRNA
Luteolin inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]
Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; NR4A1 mRNA promotes the reaction [Calcimycin results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]		 CTD PMID:1371491 PMID:16134060 PMID:17588137 PMID:17950587 PMID:18799549 More... NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfsf10 TNF superfamily member 10 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression		 ISO [[Air Pollutants results in increased abundance of Particulate Matter] which co-treated with Calcimycin] affects the expression of TP53 mRNA
Calcimycin results in increased expression of TP53 mRNA		 CTD PMID:26419736 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Tslp thymic stromal lymphopoietin multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein] CTD PMID:24131540 NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548 		JBrowse link
G Uhrf1 ubiquitin-like with PHD and ring finger domains 1 decreases expression ISO Calcimycin results in decreased expression of UHRF1 mRNA; Calcimycin results in decreased expression of UHRF1 protein CTD PMID:15964557 NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions
increases secretion
increases expression		 ISO Calcimycin inhibits the reaction [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein]]
Calcimycin results in increased secretion of VEGFA protein
Calcimycin results in increased expression of VEGFA mRNA		 CTD PMID:9743532 PMID:12147617 PMID:12788823 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Xbp1 X-box binding protein 1 increases splicing
multiple interactions		 ISO Calcimycin results in increased splicing of XBP1 mRNA
Quercetin inhibits the reaction [Calcimycin results in increased splicing of XBP1 mRNA]		 CTD PMID:19428936 NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693 		JBrowse link
G Zfp36 zinc finger protein 36 multiple interactions
increases expression		 ISO shikonin inhibits the reaction [Calcimycin results in increased expression of ZFP36 mRNA] CTD PMID:25451590 NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564 		JBrowse link
chloroprocaine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions		 ISO chloroprocaine results in increased expression of BAX protein
LINC00494 inhibits the reaction [chloroprocaine results in increased expression of BAX protein]		 CTD PMID:37650745 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions		 ISO chloroprocaine results in decreased expression of CCND1 protein
LINC00494 inhibits the reaction [chloroprocaine results in decreased expression of CCND1 protein]		 CTD PMID:37650745 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Med19 mediator complex subunit 19 decreases expression
multiple interactions		 ISO chloroprocaine results in decreased expression of MED19 mRNA; chloroprocaine results in decreased expression of MED19 protein
LINC00494 inhibits the reaction [chloroprocaine results in decreased expression of MED19 mRNA]; LINC00494 inhibits the reaction [chloroprocaine results in decreased expression of MED19 protein]		 CTD PMID:37650745 NCBI chr 3:69,762,138...69,772,661
Ensembl chr 3:69,762,166...69,772,036 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression
multiple interactions		 ISO chloroprocaine results in decreased expression of PCNA protein
LINC00494 inhibits the reaction [chloroprocaine results in decreased expression of PCNA protein]		 CTD PMID:37650745 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995 		JBrowse link
fenamic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adam17 ADAM metallopeptidase domain 17 increases response to substance ISO ADAM17 results in increased susceptibility to fenamic acid CTD PMID:12147693 NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases activity ISO fenamic acid analog results in decreased activity of AKR1C1 protein CTD PMID:19010312 NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 decreases activity ISO fenamic acid analog results in decreased activity of AKR1C2 protein CTD PMID:19010312 NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO fenamic acid analog results in decreased activity of AKR1C3 protein CTD PMID:19010312 NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions ISO fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] CTD PMID:12542607 NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720 		JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions
decreases activity		 ISO
EXP		 fenamic acid inhibits the reaction [[[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides]; fenamic acid inhibits the reaction [Colforsin results in increased activity of CFTR protein]
fenamic acid results in decreased activity of CFTR protein		 CTD PMID:14502435 PMID:14668136 PMID:15020588 PMID:15277574 PMID:15857825 More... NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 increases expression EXP fenamic acid results in increased expression of HAVCR1 mRNA CTD PMID:23142791 NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698 		JBrowse link
G Krt14 keratin 14 increases expression EXP fenamic acid results in increased expression of KRT14 mRNA CTD PMID:23142791 NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799 		JBrowse link
G Lmcd1 LIM and cysteine-rich domains 1 increases expression EXP fenamic acid results in increased expression of LMCD1 mRNA CTD PMID:23558518 NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046 		JBrowse link
G Mir210 microRNA 210 affects expression EXP fenamic acid affects the expression of MIR210 CTD PMID:30169741 NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454 		JBrowse link
G Mir34c microRNA 34c increases expression EXP fenamic acid results in increased expression of MIR34C CTD PMID:33367795 NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802 		JBrowse link
G Tgfb2 transforming growth factor, beta 2 increases expression EXP fenamic acid results in increased expression of TGFB2 mRNA CTD PMID:23558518 NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO fenamic acid inhibits the reaction [TNF protein results in increased transport of Chlorides] CTD PMID:10783394 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Vip vasoactive intestinal peptide multiple interactions ISO fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] CTD PMID:12542607 NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216 		JBrowse link
flufenamic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adam17 ADAM metallopeptidase domain 17 increases response to substance ISO ADAM17 results in increased susceptibility to Flufenamic Acid CTD PMID:12147693 NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases activity
multiple interactions		 ISO Flufenamic Acid results in decreased activity of AKR1C1 protein
Flufenamic Acid inhibits the reaction [AKR1C1 protein affects the susceptibility to Oxaliplatin]; Flufenamic Acid inhibits the reaction [AKR1C1 protein results in increased metabolism of Dihydrotestosterone]		 CTD PMID:8573067 PMID:12604236 PMID:14672942 PMID:23933386 NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 multiple interactions
decreases activity		 ISO Flufenamic Acid inhibits the reaction [AKR1C2 protein results in increased metabolism of Dihydrotestosterone]
Flufenamic Acid results in decreased activity of AKR1C2 protein		 CTD PMID:8573067 PMID:12604236 PMID:14672942 NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 affects binding
multiple interactions
decreases activity		 ISO Flufenamic Acid binds to AKR1C3 protein
Flufenamic Acid inhibits the reaction [AKR1C3 protein affects the susceptibility to oxaliplatin]; Flufenamic Acid inhibits the reaction [AKR1C3 protein results in increased metabolism of Dihydrotestosterone]
Flufenamic Acid results in decreased activity of AKR1C3 protein		 CTD PMID:12604236 PMID:14672942 PMID:14996743 PMID:23933386 NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873 		JBrowse link
G Ar androgen receptor multiple interactions
decreases expression		 ISO Flufenamic Acid analog binds to and results in decreased activity of AR protein; Flufenamic Acid binds to and results in decreased activity of AR protein
Flufenamic Acid results in decreased expression of AR mRNA; Flufenamic Acid results in decreased expression of AR protein		 CTD PMID:10537180 PMID:19645433 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Asic5 acid sensing ion channel subunit family member 5 multiple interactions ISO Flufenamic Acid binds to and results in increased activity of ASIC5 protein CTD PMID:21828194 NCBI chr 2:167,307,984...167,336,812
Ensembl chr 2:167,307,984...167,336,812 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAD protein] CTD PMID:27957685 NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] CTD PMID:27957685 NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264 		JBrowse link
G Best1 bestrophin 1 decreases activity ISO Flufenamic Acid results in decreased activity of BEST1 protein CTD PMID:19828819 NCBI chr 1:206,629,340...206,646,085
Ensembl chr 1:206,629,500...206,646,063 		JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BID protein] CTD PMID:27957685 NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form] CTD PMID:27957685 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casr calcium-sensing receptor multiple interactions ISO Flufenamic Acid promotes the reaction [CASR protein results in increased uptake of Calcium] CTD PMID:21562303 NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811 		JBrowse link
G Cftr CF transmembrane conductance regulator decreases activity ISO Flufenamic Acid results in decreased activity of CFTR protein CTD PMID:15277574 NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756 		JBrowse link
G Cga glycoprotein hormones, alpha polypeptide multiple interactions EXP [Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of CGA mRNA CTD PMID:8404651 NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191 		JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium] CTD PMID:18316702 NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356 		JBrowse link
G Dhrs11 dehydrogenase/reductase 11 decreases activity ISO Flufenamic Acid results in decreased activity of DHRS11 protein CTD PMID:30926317 NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions EXP [Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of FSHB mRNA CTD PMID:8404651 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370 		JBrowse link
G Grm1 glutamate metabotropic receptor 1 multiple interactions EXP Flufenamic Acid inhibits the reaction [3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein]; Flufenamic Acid inhibits the reaction [[3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein] which results in increased abundance of Calcium] CTD PMID:14622174 NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A protein] CTD PMID:10866999 NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822 		JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions		 EXP
ISO		 Flufenamic Acid results in increased expression of IL6 mRNA
Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]		 CTD PMID:15135310 PMID:24849676 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions ISO E 4031 inhibits the reaction [Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium]]; Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium] CTD PMID:12359267 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
G Kcnk10 potassium two pore domain channel subfamily K member 10 multiple interactions ISO Flufenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium] CTD PMID:16075240 NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695 		JBrowse link
G Kcnk2 potassium two pore domain channel subfamily K member 2 multiple interactions ISO Flufenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435 		JBrowse link
G Kcnk4 potassium two pore domain channel subfamily K member 4 multiple interactions ISO Flufenamic Acid promotes the reaction [KCNK4 protein results in increased transport of Potassium] CTD PMID:16075240 NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925 		JBrowse link
G Kiss1 KiSS-1 metastasis-suppressor multiple interactions ISO Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium] CTD PMID:18948403 NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612 		JBrowse link
G Kiss1r KISS1 receptor multiple interactions ISO Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium] CTD PMID:18948403 NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
increases expression		 ISO Flufenamic Acid inhibits the reaction [Cyclosporine inhibits the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]]; Flufenamic Acid promotes the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]; Flufenamic Acid promotes the reaction [Cholesterol, LDL binds to LDLR protein]
Flufenamic Acid results in increased expression of LDLR mRNA; Flufenamic Acid results in increased expression of LDLR protein		 CTD PMID:10395027 NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580 		JBrowse link
G Lep leptin multiple interactions ISO Flufenamic Acid inhibits the reaction [LEP protein results in increased transport of Calcium] CTD PMID:20107083 NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262 		JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions EXP [Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of LHB mRNA CTD PMID:8404651 NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases expression		 ISO
EXP		 Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
Flufenamic Acid results in increased expression of NOS2 mRNA		 CTD PMID:10866999 PMID:15135310 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Panx1 Pannexin 1 decreases activity ISO Flufenamic Acid results in decreased activity of PANX1 protein CTD PMID:19023039 NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO Flufenamic Acid binds to and results in increased activity of PPARA protein CTD PMID:9013583 NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
increases activity		 ISO [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid binds to and results in increased activity of PPARG protein CTD PMID:9013583 PMID:10866999 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression		 ISO [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]
Flufenamic Acid results in increased expression of PTGS2 mRNA; Flufenamic Acid results in increased expression of PTGS2 protein		 CTD PMID:10866999 NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Sell selectin L decreases expression ISO Flufenamic Acid results in decreased expression of SELL protein CTD PMID:12147693 NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456 		JBrowse link
G Slc6a11 solute carrier family 6 member 11 multiple interactions ISO Flufenamic Acid inhibits the reaction [SLC6A11 protein results in increased uptake of gamma-Aminobutyric Acid] CTD PMID:15981712 NCBI chr 4:147,297,972...147,413,319
Ensembl chr 4:147,297,969...147,413,443 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression		 ISO
EXP		 Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]
Flufenamic Acid results in increased expression of TNF mRNA		 CTD PMID:10866999 PMID:15135310 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Trpc6 transient receptor potential cation channel, subfamily C, member 6 multiple interactions
increases activity		 ISO
EXP		 [Flufenamic Acid results in increased activity of TRPC6 protein] which results in increased uptake of Calcium
Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Calcium]]; Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Manganese]]		 CTD PMID:11535132 PMID:14551041 PMID:21562303 NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092 		JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions EXP Flufenamic Acid inhibits the reaction [Adenosine Diphosphate Ribose promotes the reaction [TRPM2 protein results in increased transport of Calcium]] CTD PMID:21900507 NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181 		JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 decreases activity ISO
EXP		 Flufenamic Acid results in decreased activity of TRPM4 protein CTD PMID:16966582 PMID:17188667 NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532 		JBrowse link
glafenine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin increases expression EXP Glafenine results in increased expression of A2M mRNA CTD PMID:24136188 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786 		JBrowse link
G Aadac arylacetamide deacetylase decreases expression EXP Glafenine results in decreased expression of AADAC mRNA CTD PMID:24136188 NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734 		JBrowse link
G Aamdc adipogenesis associated, Mth938 domain containing decreases expression EXP Glafenine results in decreased expression of AAMDC mRNA CTD PMID:24136188 NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398 		JBrowse link
G Abat 4-aminobutyrate aminotransferase decreases expression EXP Glafenine results in decreased expression of ABAT mRNA CTD PMID:24136188 NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression EXP Glafenine results in increased expression of ABCA1 mRNA CTD PMID:24136188 NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 decreases expression EXP Glafenine results in decreased expression of ABCB11 mRNA CTD PMID:24136188 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression EXP Glafenine results in decreased expression of ABCB1 mRNA CTD PMID:24136188 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 decreases expression EXP Glafenine results in decreased expression of ABCC2 mRNA CTD PMID:24136188 NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 decreases expression EXP Glafenine results in decreased expression of ABCD3 mRNA CTD PMID:24136188 NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 decreases expression EXP Glafenine results in decreased expression of ABCG5 mRNA CTD PMID:24136188 NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563 		JBrowse link
G Abhd1 abhydrolase domain containing 1 decreases expression EXP Glafenine results in decreased expression of ABHD1 mRNA CTD PMID:24136188 NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514 		JBrowse link
G Abhd14b abhydrolase domain containing 14b decreases expression EXP Glafenine results in decreased expression of ABHD14B mRNA CTD PMID:24136188 NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119 		JBrowse link
G Abhd2 abhydrolase domain containing 2, acylglycerol lipase increases expression EXP Glafenine results in increased expression of ABHD2 mRNA CTD PMID:24136188 NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061 		JBrowse link
G Abhd6 abhydrolase domain containing 6, acylglycerol lipase decreases expression EXP Glafenine results in decreased expression of ABHD6 mRNA CTD PMID:24136188 NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985 		JBrowse link
G Abi1 abl-interactor 1 decreases expression EXP Glafenine results in decreased expression of ABI1 mRNA CTD PMID:24136188 NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792 		JBrowse link
G Abraxas2 abraxas 2, BRISC complex subunit decreases expression EXP Glafenine results in decreased expression of ABRAXAS2 mRNA CTD PMID:24136188 NCBI chr 1:187,647,078...187,672,660
Ensembl chr 1:187,647,067...187,672,655 		JBrowse link
G Abtb1 ankyrin repeat and BTB domain containing 1 decreases expression EXP Glafenine results in decreased expression of ABTB1 mRNA CTD PMID:24136188 NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620 		JBrowse link
G Abtb2 ankyrin repeat and BTB domain containing 2 decreases expression EXP Glafenine results in decreased expression of ABTB2 mRNA CTD PMID:24136188 NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548 		JBrowse link
G Abtb3 ankyrin repeat and BTB domain containing 3 decreases expression EXP Glafenine results in decreased expression of ABTB3 mRNA CTD PMID:24136188 NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834 		JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A decreases expression EXP Glafenine results in decreased expression of ACAA1 mRNA CTD PMID:24136188 NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases expression EXP Glafenine results in increased expression of ACACA mRNA CTD PMID:24136188 NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457 		JBrowse link
G Acad10 acyl-CoA dehydrogenase family, member 10 decreases expression EXP Glafenine results in decreased expression of ACAD10 mRNA CTD PMID:24136188 NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521 		JBrowse link
G Acad11 acyl-CoA dehydrogenase family, member 11 decreases expression EXP Glafenine results in decreased expression of ACAD11 mRNA CTD PMID:24136188 NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560 		JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 decreases expression EXP Glafenine results in decreased expression of ACAD9 mRNA CTD PMID:24136188 NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547 		JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain decreases expression EXP Glafenine results in decreased expression of ACADM mRNA CTD PMID:24136188 NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147 		JBrowse link
G Acads acyl-CoA dehydrogenase short chain decreases expression EXP Glafenine results in decreased expression of ACADS mRNA CTD PMID:24136188 NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898 		JBrowse link
G Acbd5 acyl-CoA binding domain containing 5 decreases expression EXP Glafenine results in decreased expression of ACBD5 mRNA CTD PMID:24136188 NCBI chr17:85,206,178...85,248,909
Ensembl chr17:85,206,303...85,248,215 		JBrowse link
G Acer2 alkaline ceramidase 2 increases expression EXP Glafenine results in increased expression of ACER2 mRNA CTD PMID:24136188 NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614 		JBrowse link
G Ackr3 atypical chemokine receptor 3 increases expression EXP Glafenine results in increased expression of ACKR3 mRNA CTD PMID:24136188 NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237 		JBrowse link
G Acot12 acyl-CoA thioesterase 12 decreases expression EXP Glafenine results in decreased expression of ACOT12 mRNA CTD PMID:24136188 NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536 		JBrowse link
G Acot2 acyl-CoA thioesterase 2 decreases expression EXP Glafenine results in decreased expression of ACOT2 mRNA CTD PMID:24136188 NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245 		JBrowse link
G Acot4 acyl-CoA thioesterase 4 decreases expression EXP Glafenine results in decreased expression of ACOT4 mRNA CTD PMID:24136188 NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917 		JBrowse link
G Acox1 acyl-CoA oxidase 1 decreases expression EXP Glafenine results in decreased expression of ACOX1 mRNA CTD PMID:24136188 NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression EXP Glafenine results in decreased expression of ACSL1 mRNA CTD PMID:24136188 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541 		JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 decreases expression EXP Glafenine results in decreased expression of ACSM2A mRNA CTD PMID:24136188 NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 decreases expression EXP Glafenine results in decreased expression of ACSS2 mRNA CTD PMID:24136188 NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675 		JBrowse link
G Actg1 actin, gamma 1 increases expression EXP Glafenine results in increased expression of ACTG1 mRNA CTD PMID:24136188 NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
Ensembl chr 3:105,619,737...105,624,232 		JBrowse link
G Adck5 aarF domain containing kinase 5 decreases expression EXP Glafenine results in decreased expression of ADCK5 mRNA CTD PMID:24136188 NCBI chr 7:108,301,623...108,319,439
Ensembl chr 7:108,301,415...108,319,436 		JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide decreases expression EXP Glafenine results in decreased expression of ADH4 mRNA CTD PMID:24136188 NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591 		JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression EXP Glafenine results in decreased expression of ADHFE1 mRNA CTD PMID:24136188 NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517 		JBrowse link
G Adipor2 adiponectin receptor 2 decreases expression EXP Glafenine results in decreased expression of ADIPOR2 mRNA CTD PMID:24136188 NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355 		JBrowse link
G Adk adenosine kinase decreases expression EXP Glafenine results in decreased expression of ADK mRNA CTD PMID:24136188 NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510 		JBrowse link
G Adss1 adenylosuccinate synthase 1 decreases expression EXP Glafenine results in decreased expression of ADSS1 mRNA CTD PMID:24136188 NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998 		JBrowse link
G Adss2 adenylosuccinate synthase 2 decreases expression EXP Glafenine results in decreased expression of ADSS2 mRNA CTD PMID:24136188 NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604 		JBrowse link
G Adtrp androgen-dependent TFPI-regulating protein decreases expression EXP Glafenine results in decreased expression of ADTRP mRNA CTD PMID:24136188 NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826 		JBrowse link
G Afm afamin decreases expression EXP Glafenine results in decreased expression of AFM mRNA CTD PMID:24136188 NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870 		JBrowse link
G Afmid arylformamidase decreases expression EXP Glafenine results in decreased expression of AFMID mRNA CTD PMID:24136188 NCBI chr10:103,046,129...103,061,718
Ensembl chr10:103,046,180...103,061,718 		JBrowse link
G Agmat agmatinase decreases expression EXP Glafenine results in decreased expression of AGMAT mRNA CTD PMID:24136188 NCBI chr 5:154,043,665...154,074,278
Ensembl chr 5:154,060,151...154,074,276 		JBrowse link
G Agmo alkylglycerol monooxygenase decreases expression EXP Glafenine results in decreased expression of AGMO mRNA CTD PMID:24136188 NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623 		JBrowse link
G Ahcy adenosylhomocysteinase decreases expression EXP Glafenine results in decreased expression of AHCY mRNA CTD PMID:24136188 NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393 		JBrowse link
G Aimp2 aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 increases expression EXP Glafenine results in increased expression of AIMP2 mRNA CTD PMID:24136188 NCBI chr12:10,701,194...10,710,772
Ensembl chr12:10,701,194...10,710,769 		JBrowse link
G Ak3 adenylate kinase 3 decreases expression EXP Glafenine results in decreased expression of AK3 mRNA CTD PMID:24136188 NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 increases expression EXP Glafenine results in increased expression of AKR1A1 mRNA CTD PMID:24136188 NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases expression EXP Glafenine results in decreased expression of AKR1C1 mRNA CTD PMID:24136188 NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G AKR1C3l1 aldo-keto reductase family 1 member C3-like 1 decreases expression EXP Glafenine results in decreased expression of AKR1C3L1 mRNA CTD PMID:24136188 NCBI chr17:65,847,580...65,881,488
Ensembl chr17:65,835,634...65,881,488 		JBrowse link
G Akr1e2 aldo-keto reductase family 1, member E2 decreases expression EXP Glafenine results in decreased expression of AKR1E2 mRNA CTD PMID:24136188 NCBI chr17:65,735,909...65,750,441
Ensembl chr17:65,735,943...65,750,441 		JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 decreases expression EXP Glafenine results in decreased expression of AKR7A2 mRNA CTD PMID:24136188 NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 decreases expression EXP Glafenine results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394 		JBrowse link
G Alas1 5'-aminolevulinate synthase 1 decreases expression EXP Glafenine results in decreased expression of ALAS1 mRNA CTD PMID:24136188 NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH1A1 mRNA CTD PMID:24136188 NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961 		JBrowse link
G Aldh1l1 aldehyde dehydrogenase 1 family, member L1 decreases expression EXP Glafenine results in decreased expression of ALDH1L1 mRNA CTD PMID:24136188 NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member decreases expression EXP Glafenine results in decreased expression of ALDH2 mRNA CTD PMID:24136188 NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 decreases expression EXP Glafenine results in decreased expression of ALDH3A2 mRNA CTD PMID:24136188 NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281 		JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH4A1 mRNA CTD PMID:24136188 NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345 		JBrowse link
G Aldh5a1 aldehyde dehydrogenase 5 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH5A1 mRNA CTD PMID:24136188 NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH6A1 mRNA CTD PMID:24136188 NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656 		JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH9A1 mRNA CTD PMID:24136188 NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A increases expression EXP Glafenine results in increased expression of ALDOA mRNA CTD PMID:24136188 NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182 		JBrowse link
G Alg12 ALG12, alpha-1,6-mannosyltransferase increases expression EXP Glafenine results in increased expression of ALG12 mRNA CTD PMID:24136188 NCBI chr 7:119,895,112...119,909,488
Ensembl chr 7:119,895,120...119,909,458 		JBrowse link
G Alg2 ALG2, alpha-1,3/1,6-mannosyltransferase increases expression EXP Glafenine results in increased expression of ALG2 mRNA CTD PMID:24136188 NCBI chr 5:61,768,738...61,773,297
Ensembl chr 5:61,768,740...61,773,297 		JBrowse link
G Alg3 ALG3, alpha-1,3- mannosyltransferase increases expression EXP Glafenine results in increased expression of ALG3 mRNA CTD PMID:24136188 NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression EXP Glafenine results in decreased expression of AMACR mRNA CTD PMID:24136188 NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255 		JBrowse link
G Amigo3 adhesion molecule with Ig like domain 3 increases expression EXP Glafenine results in increased expression of AMIGO3 mRNA CTD PMID:24136188 NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555 		JBrowse link
G Amy1 amylase alpha 1 decreases expression EXP Glafenine results in decreased expression of AMY1A mRNA CTD PMID:24136188 NCBI chr 2:201,382,678...201,397,487
Ensembl chr 2:201,382,675...201,397,816 		JBrowse link
G Ang angiogenin decreases expression EXP Glafenine results in decreased expression of ANG mRNA CTD PMID:24136188 NCBI chr15:24,312,711...24,323,361 JBrowse link
G Angptl3 angiopoietin-like 3 decreases expression EXP Glafenine results in decreased expression of ANGPTL3 mRNA CTD PMID:24136188 NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957 		JBrowse link
G Ankrd24 ankyrin repeat domain 24 increases expression EXP Glafenine results in increased expression of ANKRD24 mRNA CTD PMID:24136188 NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142 		JBrowse link
G Ankrd46 ankyrin repeat domain 46 decreases expression EXP Glafenine results in decreased expression of ANKRD46 mRNA CTD PMID:24136188 NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132 		JBrowse link
G Anks4b ankyrin repeat and sterile alpha motif domain containing 4B decreases expression EXP Glafenine results in decreased expression of ANKS4B mRNA CTD PMID:24136188 NCBI chr 1:174,534,195...174,557,798
Ensembl chr 1:174,547,473...174,557,797 		JBrowse link
G Antxr2 ANTXR cell adhesion molecule 2 decreases expression EXP Glafenine results in decreased expression of ANTXR2 mRNA CTD PMID:24136188 NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094 		JBrowse link
G Anxa4 annexin A4 decreases expression EXP Glafenine results in decreased expression of ANXA4 mRNA CTD PMID:24136188 NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161 		JBrowse link
G Apeg3 antisense paternally expressed gene 3 increases expression EXP Glafenine results in increased expression of APEG3 mRNA CTD PMID:24136188 NCBI chr 1:67,121,402...67,122,333
Ensembl chr 1:67,121,900...67,122,181
Ensembl chr 1:67,121,900...67,122,181 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases expression EXP Glafenine results in increased expression of APEX1 mRNA CTD PMID:24136188 NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785 		JBrowse link
G Apmap adipocyte plasma membrane associated protein decreases expression EXP Glafenine results in decreased expression of APMAP mRNA CTD PMID:24136188 NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341 		JBrowse link
G Apoa2 apolipoprotein A2 decreases expression EXP Glafenine results in decreased expression of APOA2 mRNA CTD PMID:24136188 NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355 		JBrowse link
G Apol9a-Apol7a Apol9a-Apol7a readthrough decreases expression EXP Glafenine results in decreased expression of APOL7B mRNA CTD PMID:24136188 NCBI chr 7:109,118,559...109,149,798
Ensembl chr 7:109,131,064...109,147,649 		JBrowse link
G Appbp2 amyloid beta precursor protein binding protein 2 decreases expression EXP Glafenine results in decreased expression of APPBP2 mRNA CTD PMID:24136188 NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835 		JBrowse link
G Aprt adenine phosphoribosyl transferase increases expression EXP Glafenine results in increased expression of APRT mRNA CTD PMID:24136188 NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431 		JBrowse link
G Arf4 ARF GTPase 4 increases expression EXP Glafenine results in increased expression of ARF4 mRNA CTD PMID:24136188 NCBI chr16:1,896,692...1,913,267
Ensembl chr16:1,896,546...1,913,261 		JBrowse link
G Arfgap3 ARF GTPase activating protein 3 increases expression EXP Glafenine results in increased expression of ARFGAP3 mRNA CTD PMID:24136188 NCBI chr 7:114,432,873...114,479,206
Ensembl chr 7:114,432,873...114,479,208 		JBrowse link
G Arfgef1 ARF guanine nucleotide exchange factor 1 decreases expression EXP Glafenine results in decreased expression of ARFGEF1 mRNA CTD PMID:24136188 NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326 		JBrowse link
G Arfip2 ARF interacting protein 2 increases expression EXP Glafenine results in increased expression of ARFIP2 mRNA CTD PMID:24136188 NCBI chr 1:159,974,255...159,980,398
Ensembl chr 1:159,974,201...159,980,336 		JBrowse link
G Arhgap1 Rho GTPase activating protein 1 increases expression EXP Glafenine results in increased expression of ARHGAP1 mRNA CTD PMID:24136188 NCBI chr 3:77,621,377...77,643,400
Ensembl chr 3:77,620,655...77,643,396 		JBrowse link
G Arhgap18 Rho GTPase activating protein 18 decreases expression EXP Glafenine results in decreased expression of ARHGAP18 mRNA CTD PMID:24136188 NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256 		JBrowse link
G Arhgap24 Rho GTPase activating protein 24 decreases expression EXP Glafenine results in decreased expression of ARHGAP24 mRNA CTD PMID:24136188 NCBI chr14:6,800,624...7,183,877
Ensembl chr14:6,800,631...7,183,823 		JBrowse link
G Arl6ip1 ARL6 interacting reticulophagy regulator 1 decreases expression EXP Glafenine results in decreased expression of ARL6IP1 mRNA CTD PMID:24136188 NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994 		JBrowse link
G Arl6ip4 ARF like GTPase 6 interacting protein 4 increases expression EXP Glafenine results in increased expression of ARL6IP4 mRNA CTD PMID:24136188 NCBI chr12:32,479,623...32,481,768
Ensembl chr12:32,479,625...32,481,799 		JBrowse link
G Armc9 armadillo repeat containing 9 increases expression EXP Glafenine results in increased expression of ARMC9 mRNA CTD PMID:24136188 NCBI chr 9:86,802,791...86,928,611
Ensembl chr 9:86,802,868...86,928,860 		JBrowse link
G Armcx3 armadillo repeat containing, X-linked 3 increases expression EXP Glafenine results in increased expression of ARMCX3 mRNA CTD PMID:24136188 NCBI chr  X:97,937,115...97,942,098
Ensembl chr  X:97,936,999...97,942,098 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B increases expression EXP Glafenine results in increased expression of ARPC1B mRNA CTD PMID:24136188 NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747 		JBrowse link
G Arpc5l actin related protein 2/3 complex, subunit 5-like increases expression EXP Glafenine results in increased expression of ARPC5L mRNA CTD PMID:24136188 NCBI chr 3:22,758,710...22,767,520
Ensembl chr 3:22,759,876...22,767,538
Ensembl chr 9:22,759,876...22,767,538 		JBrowse link
G Asl argininosuccinate lyase decreases expression EXP Glafenine results in decreased expression of ASL mRNA CTD PMID:24136188 NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662 		JBrowse link
G Ass1 argininosuccinate synthase 1 decreases expression EXP Glafenine results in decreased expression of ASS1 mRNA CTD PMID:24136188 NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903 		JBrowse link
G Atf4 activating transcription factor 4 increases expression EXP Glafenine results in increased expression of ATF4 mRNA CTD PMID:24136188 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446 		JBrowse link
G Atg13 autophagy related 13 increases expression EXP Glafenine results in increased expression of ATG13 mRNA CTD PMID:24136188 NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043 		JBrowse link
G Atg16l2 autophagy related 16-like 2 increases expression EXP Glafenine results in increased expression of ATG16L2 mRNA CTD PMID:24136188 NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420 		JBrowse link
G Atg2b autophagy related 2B decreases expression EXP Glafenine results in decreased expression of ATG2B mRNA CTD PMID:24136188 NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015 		JBrowse link
G Atl2 atlastin GTPase 2 decreases expression EXP Glafenine results in decreased expression of ATL2 mRNA CTD PMID:24136188 NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421 		JBrowse link
G Atosa atos homolog A decreases expression EXP Glafenine results in decreased expression of ATOSA mRNA CTD PMID:24136188 NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549 		JBrowse link
G Atp11a ATPase phospholipid transporting 11A decreases expression EXP Glafenine results in decreased expression of ATP11A mRNA CTD PMID:24136188 NCBI chr16:76,657,752...76,767,640
Ensembl chr16:76,657,752...76,767,640 		JBrowse link
G Atp11c ATPase phospholipid transporting 11C decreases expression EXP Glafenine results in decreased expression of ATP11C mRNA CTD PMID:24136188 NCBI chr  X:138,564,459...138,752,116
Ensembl chr  X:138,565,836...138,751,204 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 decreases expression EXP Glafenine results in decreased expression of ATP1B1 mRNA CTD PMID:24136188 NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 increases expression EXP Glafenine results in increased expression of ATP2A2 mRNA CTD PMID:24136188 NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101 		JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 increases expression EXP Glafenine results in increased expression of ATP5MC1 mRNA CTD PMID:24136188 NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124
Ensembl chr10:81,023,925...81,027,124 		JBrowse link
G Atrn attractin decreases expression EXP Glafenine results in decreased expression of ATRN mRNA CTD PMID:24136188 NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322 		JBrowse link
G Atxn2 ataxin 2 decreases expression EXP Glafenine results in decreased expression of ATXN2 mRNA CTD PMID:24136188 NCBI chr12:34,754,132...34,851,175
Ensembl chr12:34,754,137...34,851,479 		JBrowse link
G Aurkaip1 aurora kinase A interacting protein 1 increases expression EXP Glafenine results in increased expression of AURKAIP1 mRNA CTD PMID:24136188 NCBI chr 5:166,435,177...166,436,888
Ensembl chr 5:166,417,508...166,436,882 		JBrowse link
G B2m beta-2 microglobulin decreases expression EXP Glafenine results in decreased expression of B2M mRNA CTD PMID:24136188 NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766 		JBrowse link
G B4galt1 beta-1,4-galactosyltransferase 1 increases expression EXP Glafenine results in increased expression of B4GALT1 mRNA CTD PMID:24136188 NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461 		JBrowse link
G B4gat1 beta-1,4-glucuronyltransferase 1 decreases expression EXP Glafenine results in decreased expression of B4GAT1 mRNA CTD PMID:24136188 NCBI chr 1:202,343,268...202,345,490
Ensembl chr 1:202,343,240...202,346,065 		JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase decreases expression EXP Glafenine results in decreased expression of BAAT mRNA CTD PMID:24136188 NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685 		JBrowse link
G Babam1 BRISC and BRCA1 A complex member 1 increases expression EXP Glafenine results in increased expression of BABAM1 mRNA CTD PMID:24136188 NCBI chr16:18,068,830...18,074,938
Ensembl chr16:18,068,884...18,074,923 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression EXP Glafenine results in increased expression of BASP1 mRNA CTD PMID:24136188 NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043 		JBrowse link
G Bbln bublin coiled coil protein increases expression EXP Glafenine results in increased expression of BBLN mRNA CTD PMID:24136188 NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374 		JBrowse link
G Bbox1 gamma-butyrobetaine hydroxylase 1 decreases expression EXP Glafenine results in decreased expression of BBOX1 mRNA CTD PMID:24136188 NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458 		JBrowse link
G Bbs2 Bardet-Biedl syndrome 2 decreases expression EXP Glafenine results in decreased expression of BBS2 mRNA CTD PMID:24136188 NCBI chr19:10,909,653...10,944,998
Ensembl chr19:10,909,619...10,944,993 		JBrowse link
G Bcl3 BCL3, transcription coactivator increases expression EXP Glafenine results in increased expression of BCL3 mRNA CTD PMID:24136188 NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607 		JBrowse link
G Bet1l Bet1 golgi vesicular membrane trafficking protein-like increases expression EXP Glafenine results in increased expression of BET1L mRNA CTD PMID:24136188 NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 increases expression EXP Glafenine results in increased expression of BHLHE40 mRNA CTD PMID:24136188 NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase decreases expression EXP Glafenine results in decreased expression of BHMT mRNA CTD PMID:24136188 NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742 		JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 decreases expression EXP Glafenine results in decreased expression of BHMT2 mRNA CTD PMID:24136188 NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475 		JBrowse link
G Bloc1s5 biogenesis of lysosomal organelles complex 1 subunit 5 decreases expression EXP Glafenine results in decreased expression of BLOC1S5 mRNA CTD PMID:24136188 NCBI chr17:26,171,965...26,197,276
Ensembl chr17:26,172,018...26,197,251 		JBrowse link
G Blvrb biliverdin reductase B decreases expression EXP Glafenine results in decreased expression of BLVRB mRNA CTD PMID:24136188 NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375 		JBrowse link
G Bnip1 BCL2 interacting protein 1 increases expression EXP Glafenine results in increased expression of BNIP1 mRNA CTD PMID:24136188 NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157 		JBrowse link
G Bnip3l BCL2 interacting protein 3 like decreases expression EXP Glafenine results in decreased expression of BNIP3L mRNA CTD PMID:24136188 NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803 		JBrowse link
G Bola2-ps4 bolA family member 2, pseudogene 4 increases expression EXP Glafenine results in increased expression of BOLA2-PS4 mRNA CTD PMID:24136188 NCBI chr 3:153,272,435...153,272,781 JBrowse link
G Bola3 bolA family member 3 increases expression EXP Glafenine results in increased expression of BOLA3 mRNA CTD PMID:24136188 NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797 		JBrowse link
G Bop1 BOP1 ribosomal biogenesis factor increases expression EXP Glafenine results in increased expression of BOP1 mRNA CTD PMID:24136188 NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931 		JBrowse link
G Borcs7 BLOC-1 related complex subunit 7 increases expression EXP Glafenine results in increased expression of BORCS7 mRNA CTD PMID:24136188 NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343 		JBrowse link
G Bphl biphenyl hydrolase like decreases expression EXP Glafenine results in decreased expression of BPHL mRNA CTD PMID:24136188 NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288 		JBrowse link
G Brd3 bromodomain containing 3 decreases expression EXP Glafenine results in decreased expression of BRD3 mRNA CTD PMID:24136188 NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577 		JBrowse link
G Brix1 biogenesis of ribosomes BRX1 increases expression EXP Glafenine results in increased expression of BRIX1 mRNA CTD PMID:24136188 NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:59,450,614...59,461,495 		JBrowse link
G Btbd1 BTB domain containing 1 decreases expression EXP Glafenine results in decreased expression of BTBD1 mRNA CTD PMID:24136188 NCBI chr 1:135,734,549...135,773,067
Ensembl chr 1:135,734,589...135,771,981 		JBrowse link
G Btbd6 BTB domain containing 6 decreases expression EXP Glafenine results in decreased expression of BTBD6 mRNA CTD PMID:24136188 NCBI chr 6:132,058,094...132,060,603
Ensembl chr 6:132,058,096...132,060,587 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression EXP Glafenine results in increased expression of BTG2 mRNA CTD PMID:24136188 NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 increases expression EXP Glafenine results in increased expression of BTG3 mRNA CTD PMID:24136188 NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170 		JBrowse link
G Bysl bystin-like increases expression EXP Glafenine results in increased expression of BYSL mRNA CTD PMID:24136188 NCBI chr 9:13,382,806...13,392,557
Ensembl chr 9:13,382,557...13,394,339 		JBrowse link
G C10h17orf58 similar to human chromosome 17 open reading frame 58 increases expression EXP Glafenine results in increased expression of C10H17ORF58 mRNA CTD PMID:24136188 NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602 		JBrowse link
G C15h14orf119 similar to human chromosome 14 open reading frame 119 increases expression EXP Glafenine results in increased expression of C15H14ORF119 mRNA CTD PMID:24136188 NCBI chr15:28,146,368...28,151,422
Ensembl chr15:28,146,333...28,155,180 		JBrowse link
G C18h18orf32 similar to human chromosome 18 open reading frame 32 increases expression EXP Glafenine results in increased expression of C18H18ORF32 mRNA CTD PMID:24136188 NCBI chr18:68,586,278...68,594,851
Ensembl chr18:68,586,211...68,596,787 		JBrowse link
G C1qbp complement C1q binding protein increases expression EXP Glafenine results in increased expression of C1QBP mRNA CTD PMID:24136188 NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649 		JBrowse link
G C4bpb complement component 4 binding protein, beta increases expression EXP Glafenine results in increased expression of C4BPB mRNA CTD PMID:24136188 NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817 		JBrowse link
G C5 complement C5 increases expression EXP Glafenine results in increased expression of C5 mRNA CTD PMID:24136188 NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994 		JBrowse link
G C5h1orf122 similar to human chromosome 1 open reading frame 122 increases expression EXP Glafenine results in increased expression of C5H1ORF122 mRNA CTD PMID:24136188 NCBI chr 5:137,109,093...137,110,130
Ensembl chr 5:137,108,633...137,110,929 		JBrowse link
G C8h11orf54 similar to human chromosome 11 open reading frame 54 decreases expression EXP Glafenine results in decreased expression of C8H11ORF54 mRNA CTD PMID:24136188 NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473 		JBrowse link
G C9 complement C9 increases expression EXP Glafenine results in increased expression of C9 mRNA CTD PMID:24136188 NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase increases expression EXP Glafenine results in increased expression of CAD mRNA CTD PMID:24136188 NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861 		JBrowse link
G Calm1 calmodulin 1 increases expression EXP Glafenine results in increased expression of CALM1 mRNA CTD PMID:24136188 NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227 		JBrowse link
G Calr calreticulin increases expression EXP Glafenine results in increased expression of CALR mRNA CTD PMID:24136188 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414 		JBrowse link
G Calu calumenin increases expression EXP Glafenine results in increased expression of CALU mRNA CTD PMID:24136188 NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593 		JBrowse link
G Caprin1 cell cycle associated protein 1 decreases expression EXP Glafenine results in decreased expression of CAPRIN1 mRNA CTD PMID:24136188 NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502 		JBrowse link
G Car14 carbonic anhydrase 14 decreases expression EXP Glafenine results in decreased expression of CAR14 mRNA CTD PMID:24136188 NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693 		JBrowse link
G Car3 carbonic anhydrase 3 decreases expression EXP Glafenine results in decreased expression of CAR3 mRNA CTD PMID:24136188 NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280 		JBrowse link
G Car5a carbonic anhydrase 5A decreases expression EXP Glafenine results in decreased expression of CAR5A mRNA CTD PMID:24136188 NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906 		JBrowse link
G Car8 carbonic anhydrase 8 increases expression EXP Glafenine results in increased expression of CAR8 mRNA CTD PMID:24136188 NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 increases expression EXP Glafenine results in increased expression of CARS1 mRNA CTD PMID:24136188 NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941 		JBrowse link
G Cars2 cysteinyl-tRNA synthetase 2, mitochondrial decreases expression EXP Glafenine results in decreased expression of CARS2 mRNA CTD PMID:24136188 NCBI chr16:77,945,468...77,987,163
Ensembl chr16:77,950,008...77,987,772 		JBrowse link
G Cat catalase decreases expression EXP Glafenine results in decreased expression of CAT mRNA CTD PMID:24136188 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cav2 caveolin 2 increases expression EXP Glafenine results in increased expression of CAV2 mRNA CTD PMID:24136188 NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244 		JBrowse link
G Cbr4 carbonyl reductase 4 decreases expression EXP Glafenine results in decreased expression of CBR4 mRNA CTD PMID:24136188 NCBI chr16:28,629,928...28,684,230
Ensembl chr16:28,617,224...28,645,712 		JBrowse link
G Ccdc125 coiled-coil domain containing 125 increases expression EXP Glafenine results in increased expression of CCDC125 mRNA CTD PMID:24136188 NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152 		JBrowse link
G Ccdc134 coiled-coil domain containing 134 increases expression EXP Glafenine results in increased expression of CCDC134 mRNA CTD PMID:24136188 NCBI chr 7:113,644,557...113,659,050
Ensembl chr 7:113,644,639...113,659,050 		JBrowse link
G Ccdc167 coiled-coil domain containing 167 increases expression EXP Glafenine results in increased expression of CCDC167 mRNA CTD PMID:24136188 NCBI chr20:7,763,927...7,782,090
Ensembl chr20:7,751,782...7,781,613 		JBrowse link
G Ccdc28a coiled-coil domain containing 28A decreases expression EXP Glafenine results in decreased expression of CCDC28A mRNA CTD PMID:24136188 NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003 		JBrowse link
G Ccdc86 coiled-coil domain containing 86 increases expression EXP Glafenine results in increased expression of CCDC86 mRNA CTD PMID:24136188 NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544 		JBrowse link
G Ccng2 cyclin G2 decreases expression EXP Glafenine results in decreased expression of CCNG2 mRNA CTD PMID:24136188 NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830 		JBrowse link
G Ccni cyclin I decreases expression EXP Glafenine results in decreased expression of CCNI mRNA CTD PMID:24136188 NCBI chr14:14,879,698...14,902,510
Ensembl chr14:14,879,717...14,902,510 		JBrowse link
G Cd2bp2 Cd2 (cytoplasmic tail) binding protein 2 increases expression EXP Glafenine results in increased expression of CD2BP2 mRNA CTD PMID:24136188 NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448 		JBrowse link
G Cd48 Cd48 molecule increases expression EXP Glafenine results in increased expression of CD48 mRNA CTD PMID:24136188 NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142 		JBrowse link
G Cd59b CD59b molecule decreases expression EXP Glafenine results in decreased expression of CD59 mRNA CTD PMID:24136188 NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847 		JBrowse link
G Cdadc1 cytidine and dCMP deaminase domain containing 1 decreases expression EXP Glafenine results in decreased expression of CDADC1 mRNA CTD PMID:24136188 NCBI chr15:33,726,590...33,755,611
Ensembl chr15:33,723,435...33,755,576 		JBrowse link
G Cdc42se1 CDC42 small effector 1 increases expression EXP Glafenine results in increased expression of CDC42SE1 mRNA CTD PMID:24136188 NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028 		JBrowse link
G Cdc5l cell division cycle 5-like decreases expression EXP Glafenine results in decreased expression of CDC5L mRNA CTD PMID:24136188 NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450 		JBrowse link
G Cdh2 cadherin 2 decreases expression EXP Glafenine results in decreased expression of CDH2 mRNA CTD PMID:24136188 NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167 		JBrowse link
G Cdip1 cell death-inducing p53 target 1 decreases expression EXP Glafenine results in decreased expression of CDIP1 mRNA CTD PMID:24136188 NCBI chr10:10,773,538...10,796,979
Ensembl chr10:10,774,705...10,796,980 		JBrowse link
G Cdk2ap1 cyclin-dependent kinase 2 associated protein 1 increases expression EXP Glafenine results in increased expression of CDK2AP1 mRNA CTD PMID:24136188 NCBI chr12:32,249,752...32,258,483
Ensembl chr12:32,249,747...32,258,479 		JBrowse link
G Cdk2ap2 cyclin-dependent kinase 2 associated protein 2 increases expression EXP Glafenine results in increased expression of CDK2AP2 mRNA CTD PMID:24136188 NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression EXP Glafenine results in increased expression of CDK4 mRNA CTD PMID:24136188 NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression EXP Glafenine results in increased expression of CDKN1A mRNA CTD PMID:24136188 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression EXP Glafenine results in decreased expression of CDKN1B mRNA CTD PMID:24136188 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 decreases expression EXP Glafenine results in decreased expression of CDKN3 mRNA CTD PMID:24136188 NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945 		JBrowse link
G Cdo1 cysteine dioxygenase type 1 decreases expression EXP Glafenine results in decreased expression of CDO1 mRNA CTD PMID:24136188 NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 decreases expression EXP Glafenine results in decreased expression of CEACAM1 mRNA CTD PMID:24136188 NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression EXP Glafenine results in increased expression of CEBPD mRNA CTD PMID:24136188 NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829 		JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 increases expression EXP Glafenine results in increased expression of CEMIP2 mRNA CTD PMID:24136188 NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760 		JBrowse link
G Cept1 choline/ethanolamine phosphotransferase 1 decreases expression EXP Glafenine results in decreased expression of CEPT1 mRNA CTD PMID:24136188 NCBI chr 2:193,994,220...194,036,141
Ensembl chr 2:193,993,447...194,035,578 		JBrowse link
G Ces1d carboxylesterase 1D decreases expression EXP Glafenine results in decreased expression of CES1D mRNA CTD PMID:24136188 NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035 		JBrowse link
G Chac2 ChaC glutathione specific gamma-glutamylcyclotransferase 2 decreases expression EXP Glafenine results in decreased expression of CHAC2 mRNA CTD PMID:24136188 NCBI chr14:104,720,754...104,728,305
Ensembl chr14:104,720,758...104,728,301 		JBrowse link
G Chchd6 coiled-coil-helix-coiled-coil-helix domain containing 6 increases expression EXP Glafenine results in increased expression of CHCHD6 mRNA CTD PMID:24136188 NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216 		JBrowse link
G Chid1 chitinase domain containing 1 increases expression EXP Glafenine results in increased expression of CHID1 mRNA CTD PMID:24136188 NCBI chr 1:196,594,357...196,629,700
Ensembl chr 1:196,587,509...196,629,606 		JBrowse link
G Chmp4c charged multivesicular body protein 4C decreases expression EXP Glafenine results in decreased expression of CHMP4C mRNA CTD PMID:24136188 NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668 		JBrowse link
G Chpf2 chondroitin polymerizing factor 2 increases expression EXP Glafenine results in increased expression of CHPF2 mRNA CTD PMID:24136188 NCBI chr 4:10,578,470...10,585,940
Ensembl chr 4:10,580,462...10,585,916 		JBrowse link
G Cic capicua transcriptional repressor increases expression EXP Glafenine results in increased expression of CIC mRNA CTD PMID:24136188 NCBI chr 1:80,853,920...80,880,537
Ensembl chr 1:80,853,920...80,880,532 		JBrowse link
G Cinp cyclin-dependent kinase 2-interacting protein increases expression EXP Glafenine results in increased expression of CINP mRNA CTD PMID:24136188 NCBI chr 6:129,878,618...129,899,575
Ensembl chr 6:129,885,570...129,899,480 		JBrowse link
G Cisd2 CDGSH iron sulfur domain 2 increases expression EXP Glafenine results in increased expression of CISD2 mRNA CTD PMID:24136188 NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B increases expression EXP Glafenine results in increased expression of CKS1B mRNA CTD PMID:24136188 NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636 		JBrowse link
G Clcn4 chloride voltage-gated channel 4 decreases expression EXP Glafenine results in decreased expression of CLCN4 mRNA CTD PMID:24136188 NCBI chr  X:23,729,194...23,795,391
Ensembl chr  X:23,729,338...23,793,238 		JBrowse link
G Clic1 chloride intracellular channel 1 increases expression EXP Glafenine results in increased expression of CLIC1 mRNA CTD PMID:24136188 NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712 		JBrowse link
G Clpx caseinolytic mitochondrial matrix peptidase chaperone subunit X decreases expression EXP Glafenine results in decreased expression of CLPX mRNA CTD PMID:24136188 NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082 		JBrowse link
G Cmbl carboxymethylenebutenolidase homolog decreases expression EXP Glafenine results in decreased expression of CMBL mRNA CTD PMID:24136188 NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009 		JBrowse link
G Cmtr1 cap methyltransferase 1 decreases expression EXP Glafenine results in decreased expression of CMTR1 mRNA CTD PMID:24136188 NCBI chr20:7,722,729...7,782,579
Ensembl chr20:7,709,713...7,766,302 		JBrowse link
G Cnn2 calponin 2 increases expression EXP Glafenine results in increased expression of CNN2 mRNA CTD PMID:24136188 NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656 		JBrowse link
G Cnppd1 cyclin Pas1/PHO80 domain containing 1 decreases expression EXP Glafenine results in decreased expression of CNPPD1 mRNA CTD PMID:24136188 NCBI chr 9:76,633,475...76,640,164
Ensembl chr 9:76,633,477...76,640,188 		JBrowse link
G Cnpy2 canopy FGF signaling regulator 2 increases expression EXP Glafenine results in increased expression of CNPY2 mRNA CTD PMID:24136188 NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519 		JBrowse link
G Cnpy3 canopy FGF signaling regulator 3 increases expression EXP Glafenine results in increased expression of CNPY3 mRNA CTD PMID:24136188 NCBI chr 9:14,233,478...14,247,847
Ensembl chr 9:14,233,428...14,247,831 		JBrowse link
G Coasy Coenzyme A synthase decreases expression EXP Glafenine results in decreased expression of COASY mRNA CTD PMID:24136188 NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841 		JBrowse link
G Cog3 component of oligomeric golgi complex 3 increases expression EXP Glafenine results in increased expression of COG3 mRNA CTD PMID:24136188 NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570 		JBrowse link
G Cog4 component of oligomeric golgi complex 4 decreases expression EXP Glafenine results in decreased expression of COG4 mRNA CTD PMID:24136188 NCBI chr19:38,820,478...38,854,803
Ensembl chr19:38,820,501...38,854,796 		JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain increases expression EXP Glafenine results in increased expression of COL18A1 mRNA CTD PMID:24136188 NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain increases expression EXP Glafenine results in increased expression of COL4A1 mRNA CTD PMID:24136188 NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412 		JBrowse link
G Copa COPI coat complex subunit alpha increases expression EXP Glafenine results in increased expression of COPA mRNA CTD PMID:24136188 NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874 		JBrowse link
G Cope COPI coat complex subunit epsilon increases expression EXP Glafenine results in increased expression of COPE mRNA CTD PMID:24136188 NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907 		JBrowse link
G Copg1 COPI coat complex subunit gamma 1 increases expression EXP Glafenine results in increased expression of COPG1 mRNA CTD PMID:24136188 NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616 		JBrowse link
G Copg2 COPI coat complex subunit gamma 2 decreases expression EXP Glafenine results in decreased expression of COPG2 mRNA CTD PMID:24136188 NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618 		JBrowse link
G Copz1 COPI coat complex subunit zeta 1 increases expression EXP Glafenine results in increased expression of COPZ1 mRNA CTD PMID:24136188 NCBI chr 7:134,409,523...134,435,661
Ensembl chr 7:134,409,799...134,435,662 		JBrowse link
G Copz2 COPI coat complex subunit zeta 2 increases expression EXP Glafenine results in increased expression of COPZ2 mRNA CTD PMID:24136188 NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514 		JBrowse link
G Coq10a coenzyme Q10A decreases expression EXP Glafenine results in decreased expression of COQ10A mRNA CTD PMID:24136188 NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161 		JBrowse link
G Coq10b coenzyme Q10B increases expression EXP Glafenine results in increased expression of COQ10B mRNA CTD PMID:24136188 NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663 		JBrowse link
G Coq8a coenzyme Q8A decreases expression EXP Glafenine results in decreased expression of COQ8A mRNA CTD PMID:24136188 NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 increases expression EXP Glafenine results in increased expression of COTL1 mRNA CTD PMID:24136188 NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689 		JBrowse link
G Cox5a cytochrome c oxidase subunit 5A decreases expression EXP Glafenine results in decreased expression of COX5A mRNA CTD PMID:24136188 NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781 		JBrowse link
G Cox5b cytochrome c oxidase subunit 5B increases expression EXP Glafenine results in increased expression of COX5B mRNA CTD PMID:24136188 NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052 		JBrowse link
G Cp ceruloplasmin increases expression EXP Glafenine results in increased expression of CP mRNA CTD PMID:24136188 NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075 		JBrowse link
G Cpne3 copine 3 decreases expression EXP Glafenine results in decreased expression of CPNE3 mRNA CTD PMID:24136188 NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934 		JBrowse link
G Cpne8 copine 8 increases expression EXP Glafenine results in increased expression of CPNE8 mRNA CTD PMID:24136188 NCBI chr 7:121,615,293...121,789,507
Ensembl chr 7:121,615,294...121,790,377 		JBrowse link
G Cpped1 calcineurin-like phosphoesterase domain containing 1 decreases expression EXP Glafenine results in decreased expression of CPPED1 mRNA CTD PMID:24136188 NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054 		JBrowse link
G Cpq carboxypeptidase Q decreases expression EXP Glafenine results in decreased expression of PGCP mRNA CTD PMID:24136188 NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546 		JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 decreases expression EXP Glafenine results in decreased expression of CPS1 mRNA CTD PMID:24136188 NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 decreases expression EXP Glafenine results in decreased expression of CPT2 mRNA CTD PMID:24136188 NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095 		JBrowse link
G Crat carnitine O-acetyltransferase decreases expression EXP Glafenine results in decreased expression of CRAT mRNA CTD PMID:24136188 NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255 		JBrowse link
G Crbn cereblon decreases expression EXP Glafenine results in decreased expression of CRBN mRNA CTD PMID:24136188 NCBI chr 4:139,701,154...139,719,949
Ensembl chr 4:139,701,094...139,719,938 		JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 decreases expression EXP Glafenine results in decreased expression of CREB3L3 mRNA CTD PMID:24136188 NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048 		JBrowse link
G Crebzf CREB/ATF bZIP transcription factor decreases expression EXP Glafenine results in decreased expression of CREBZF mRNA CTD PMID:24136188 NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553 		JBrowse link
G Creld2 cysteine-rich with EGF-like domains 2 increases expression EXP Glafenine results in increased expression of CRELD2 mRNA CTD PMID:24136188 NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543 		JBrowse link
G Crem cAMP responsive element modulator decreases expression EXP Glafenine results in decreased expression of CREM mRNA CTD PMID:24136188 NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989 		JBrowse link
G Crls1 cardiolipin synthase 1 decreases expression EXP Glafenine results in decreased expression of CRLS1 mRNA CTD PMID:24136188 NCBI chr 3:120,119,822...120,138,674
Ensembl chr 3:120,119,852...120,138,655 		JBrowse link
G Crot carnitine O-octanoyltransferase decreases expression EXP Glafenine results in decreased expression of CROT mRNA CTD PMID:24136188 NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109 		JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 decreases expression EXP Glafenine results in decreased expression of CRYBG2 mRNA CTD PMID:24136188 NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666 		JBrowse link
G Cryl1 crystallin, lambda 1 decreases expression EXP Glafenine results in decreased expression of CRYL1 mRNA CTD PMID:24136188 NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997 		JBrowse link
G Crym crystallin, mu decreases expression EXP Glafenine results in decreased expression of CRYM mRNA CTD PMID:24136188 NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633 		JBrowse link
G Cryz crystallin zeta decreases expression EXP Glafenine results in decreased expression of CRYZ mRNA CTD PMID:24136188 NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758 		JBrowse link
G Csf1 colony stimulating factor 1 increases expression EXP Glafenine results in increased expression of CSF1 mRNA CTD PMID:24136188 NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704 		JBrowse link
G Ctbs chitobiase decreases expression EXP Glafenine results in decreased expression of CTBS mRNA CTD PMID:24136188 NCBI chr 2:235,340,520...235,355,091
Ensembl chr 2:235,340,547...235,355,091 		JBrowse link
G Cth cystathionine gamma-lyase decreases expression EXP Glafenine results in decreased expression of CTH mRNA CTD PMID:24136188 NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234 		JBrowse link
G Ctnna1 catenin alpha 1 decreases expression EXP Glafenine results in decreased expression of CTNNA1 mRNA CTD PMID:24136188 NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910 		JBrowse link
G Ctps1 CTP synthase 1 increases expression EXP Glafenine results in increased expression of CTPS1 mRNA CTD PMID:24136188 NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180 		JBrowse link
G Ctsa cathepsin A decreases expression EXP Glafenine results in decreased expression of CTSA mRNA CTD PMID:24136188 NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215 		JBrowse link
G Ctsf cathepsin F decreases expression EXP Glafenine results in decreased expression of CTSF mRNA CTD PMID:24136188 NCBI chr 1:202,152,777...202,158,525
Ensembl chr 1:202,152,728...202,158,525 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 increases expression EXP Glafenine results in increased expression of CXCL1 mRNA CTD PMID:24136188 NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression EXP Glafenine results in decreased expression of CXCL12 mRNA CTD PMID:24136188 NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 decreases expression EXP Glafenine results in decreased expression of CXCL9 mRNA CTD PMID:24136188 NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 decreases expression EXP Glafenine results in decreased expression of CYB5R3 mRNA CTD PMID:24136188 NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP17A1 mRNA CTD PMID:24136188 NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity ISO Glafenine results in decreased activity of CYP1A1 protein CTD PMID:33814510 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity ISO Glafenine results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP27A1 mRNA CTD PMID:24136188 NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551 		JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2A1 mRNA CTD PMID:24136188 NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887 		JBrowse link
G Cyp2a2 cytochrome P450, family 2, subfamily a, polypeptide 2 decreases expression EXP Glafenine results in decreased expression of CYP2A2 mRNA CTD PMID:24136188 NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2B1 mRNA CTD PMID:24136188 NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052 		JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 decreases expression EXP Glafenine results in decreased expression of CYP2C11 mRNA CTD PMID:24136188 NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066 		JBrowse link
G Cyp2d1 cytochrome P450, family 2, subfamily d, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2D1 mRNA CTD PMID:24136188 NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084 		JBrowse link
G Cyp2d2 cytochrome P450, family 2, subfamily d, polypeptide 2 decreases expression EXP Glafenine results in decreased expression of CYP2D2 mRNA CTD PMID:24136188 NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209 		JBrowse link
G Cyp2d3 cytochrome P450, family 2, subfamily d, polypeptide 3 decreases expression EXP Glafenine results in decreased expression of CYP2D3 mRNA CTD PMID:24136188 NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 decreases expression EXP Glafenine results in decreased expression of CYP2D4 mRNA CTD PMID:24136188 NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2E1 mRNA CTD PMID:24136188 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp2j3 cytochrome P450, family 2, subfamily j, polypeptide 3 decreases expression EXP Glafenine results in decreased expression of CYP2J3 mRNA CTD PMID:24136188 NCBI chr 5:111,219,921...111,244,987
Ensembl chr 5:111,178,703...111,244,794 		JBrowse link
G Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 decreases expression EXP Glafenine results in decreased expression of CYP2J4 mRNA CTD PMID:24136188 NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794 		JBrowse link
G Cyp2t1 cytochrome P450, family 2, subfamily t, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2T1 mRNA CTD PMID:24136188 NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563 		JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP39A1 mRNA CTD PMID:24136188 NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775 		JBrowse link
G Cyp3a18 cytochrome P450, family 3, subfamily a, polypeptide 18 decreases expression EXP Glafenine results in decreased expression of CYP3A18 mRNA CTD PMID:24136188 NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases expression EXP Glafenine results in decreased expression of CYP3A2 mRNA CTD PMID:24136188 NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:24136188 NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
Ensembl chr12:9,254,475...9,285,030 		JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP4A1 mRNA CTD PMID:24136188 NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464 		JBrowse link
G Cyp4f1 cytochrome P450, family 4, subfamily f, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP4F1 mRNA CTD PMID:24136188 NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046 		JBrowse link
G Cyp4f4 cytochrome P450, family 4, subfamily f, polypeptide 4 decreases expression EXP Glafenine results in decreased expression of CYP4F4 mRNA CTD PMID:24136188 NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506 		JBrowse link
G Dad1 defender against cell death 1 increases expression EXP Glafenine results in increased expression of DAD1 mRNA CTD PMID:24136188 NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347 		JBrowse link
G Dao D-amino-acid oxidase decreases expression EXP Glafenine results in decreased expression of DAO mRNA CTD PMID:24136188 NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741 		JBrowse link
G Dap death-associated protein increases expression EXP Glafenine results in increased expression of DAP mRNA CTD PMID:24136188 NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752 		JBrowse link
G Dcaf11 DDB1 and CUL4 associated factor 11 decreases expression EXP Glafenine results in decreased expression of DCAF11 mRNA CTD PMID:24136188 NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669 		JBrowse link
G Dcaf6 DDB1 and CUL4 associated factor 6 decreases expression EXP Glafenine results in decreased expression of DCAF6 mRNA CTD PMID:24136188 NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512 		JBrowse link
G Dcun1d4 defective in cullin neddylation 1 domain containing 4 decreases expression EXP Glafenine results in decreased expression of DCUN1D4 mRNA CTD PMID:24136188 NCBI chr14:34,652,723...34,733,122
Ensembl chr14:34,652,723...34,733,207 		JBrowse link
G Dda1 DET1 and DDB1 associated 1 increases expression EXP Glafenine results in increased expression of DDA1 mRNA CTD PMID:24136188 NCBI chr16:18,156,310...18,163,938
Ensembl chr16:18,156,386...18,163,937 		JBrowse link
G Ddc dopa decarboxylase decreases expression EXP Glafenine results in decreased expression of DDC mRNA CTD PMID:24136188 NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO Glafenine results in increased expression of DDIT3 mRNA CTD PMID:24136188 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit increases expression EXP Glafenine results in increased expression of DDOST mRNA CTD PMID:24136188 NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413 		JBrowse link
G Ddx39a DExD-box helicase 39A increases expression EXP Glafenine results in increased expression of DDX39A mRNA CTD PMID:24136188 NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954 		JBrowse link
G Ddx39b DExD-box helicase 39B increases expression EXP Glafenine results in increased expression of DDX39B mRNA CTD PMID:24136188 NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996 		JBrowse link
G Ddx49 DEAD-box helicase 49 increases expression EXP Glafenine results in increased expression of DDX49 mRNA CTD PMID:24136188 NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616 		JBrowse link
G Decr2 2,4-dienoyl-CoA reductase 2 decreases expression EXP Glafenine results in decreased expression of DECR2 mRNA CTD PMID:24136188 NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479 		JBrowse link
G Dek DEK proto-oncogene decreases expression EXP Glafenine results in decreased expression of DEK mRNA CTD PMID:24136188 NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808 		JBrowse link
G Dennd6a DENN domain containing 6A decreases expression EXP Glafenine results in decreased expression of DENND6A mRNA CTD PMID:24136188 NCBI chr16:1,837,019...1,885,420
Ensembl chr16:1,837,059...1,885,420 		JBrowse link
G Depdc7 DEP domain containing 7 decreases expression EXP Glafenine results in decreased expression of DEPDC7 mRNA CTD PMID:24136188 NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124 		JBrowse link
G Dera deoxyribose-phosphate aldolase decreases expression EXP Glafenine results in decreased expression of DERA mRNA CTD PMID:24136188 NCBI chr 4:170,663,689...170,742,469
Ensembl chr 4:170,663,665...170,758,865 		JBrowse link
G Derl1 derlin 1 increases expression EXP Glafenine results in increased expression of DERL1 mRNA CTD PMID:24136188 NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145 		JBrowse link
G Desi2 desumoylating isopeptidase 2 increases expression EXP Glafenine results in increased expression of DESI2 mRNA CTD PMID:24136188 NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416 		JBrowse link
G Dhcr24 24-dehydrocholesterol reductase increases expression EXP Glafenine results in increased expression of DHCR24 mRNA CTD PMID:24136188 NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137 		JBrowse link
G Dhodh dihydroorotate dehydrogenase increases expression EXP Glafenine results in increased expression of DHODH mRNA CTD PMID:24136188 NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 decreases expression EXP Glafenine results in decreased expression of DHRS3 mRNA CTD PMID:24136188 NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417 		JBrowse link
G Dhrs7b dehydrogenase/reductase 7B increases expression EXP Glafenine results in increased expression of DHRS7B mRNA CTD PMID:24136188 NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076 		JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 decreases expression EXP Glafenine results in decreased expression of DHTKD1 mRNA CTD PMID:24136188 NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression EXP Glafenine results in increased expression of DMBT1 mRNA CTD PMID:24136188 NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478 		JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression EXP Glafenine results in decreased expression of DMGDH mRNA CTD PMID:24136188 NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528 		JBrowse link
G Dnaaf9 dynein axonemal assembly factor 9 decreases expression EXP Glafenine results in decreased expression of DNAAF9 mRNA CTD PMID:24136188 NCBI chr 3:117,918,047...118,052,641
Ensembl chr 3:117,921,620...118,052,630 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 increases expression EXP Glafenine results in increased expression of DNAJB11 mRNA CTD PMID:24136188 NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression EXP Glafenine results in increased expression of DNAJB9 mRNA CTD PMID:24136188 NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063 		JBrowse link
G Dnajc15 DnaJ heat shock protein family (Hsp40) member C15 increases expression EXP Glafenine results in increased expression of DNAJC15 mRNA CTD PMID:24136188 NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 increases expression EXP Glafenine results in increased expression of DNAJC3 mRNA CTD PMID:24136188 NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181 		JBrowse link
G Dnlz DNL-type zinc finger increases expression EXP Glafenine results in increased expression of DNLZ mRNA CTD PMID:24136188 NCBI chr 3:9,169,948...9,171,727
Ensembl chr 3:9,169,793...9,180,551 		JBrowse link
G Dock9 dedicator of cytokinesis 9 decreases expression EXP Glafenine results in decreased expression of DOCK9 mRNA CTD PMID:24136188 NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153 		JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression EXP Glafenine results in increased expression of DPAGT1 mRNA CTD PMID:24136188 NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087 		JBrowse link
G Dph1 diphthamide biosynthesis 1 increases expression EXP Glafenine results in increased expression of DPH1 mRNA CTD PMID:24136188 NCBI chr10:60,028,081...60,039,764
Ensembl chr10:60,026,048...60,039,850 		JBrowse link
G Dph3 diphthamide biosynthesis 3 increases expression EXP Glafenine results in increased expression of DPH3 mRNA CTD PMID:24136188 NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265 		JBrowse link
G Dph5 diphthamide biosynthesis 5 increases expression EXP Glafenine results in increased expression of DPH5 mRNA CTD PMID:24136188 NCBI chr 2:203,804,620...203,858,196
Ensembl chr 2:203,804,936...203,840,433 		JBrowse link
G Dpm3 dolichyl-phosphate mannosyltransferase subunit 3, regulatory increases expression EXP Glafenine results in increased expression of DPM3 mRNA CTD PMID:24136188 NCBI chr 2:174,676,532...174,677,047
Ensembl chr 2:174,676,363...174,677,668
Ensembl chr15:174,676,363...174,677,668 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression EXP Glafenine results in decreased expression of DPP4 mRNA CTD PMID:24136188 NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase decreases expression EXP Glafenine results in decreased expression of DPYD mRNA CTD PMID:24136188 NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982 		JBrowse link
G Dpys dihydropyrimidinase decreases expression EXP Glafenine results in decreased expression of DPYS mRNA CTD PMID:24136188 NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231 		JBrowse link
G Dram2 DNA damage regulated autophagy modulator 2 decreases expression EXP Glafenine results in decreased expression of DRAM2 mRNA CTD PMID:24136188 NCBI chr 2:194,035,624...194,064,415
Ensembl chr 2:194,035,818...194,063,403 		JBrowse link
G Drap1 Dr1 associated protein 1 increases expression EXP Glafenine results in increased expression of DRAP1 mRNA CTD PMID:24136188 NCBI chr 1:202,731,775...202,734,468
Ensembl chr 1:202,731,788...202,734,425 		JBrowse link
G Dsc2 desmocollin 2 increases expression EXP Glafenine results in increased expression of DSC2 mRNA CTD PMID:24136188 NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392 		JBrowse link
G Dsp desmoplakin decreases expression EXP Glafenine results in decreased expression of DSP mRNA CTD PMID:24136188 NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800 		JBrowse link
G Dusp11 dual specificity phosphatase 11 increases expression EXP Glafenine results in increased expression of DUSP11 mRNA CTD PMID:24136188 NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181 		JBrowse link
G Dynll1 dynein light chain LC8-type 1 increases expression EXP Glafenine results in increased expression of DYNLL1 mRNA CTD PMID:24136188 NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741 		JBrowse link
G Dynlt1 dynein light chain Tctex-type 1 increases expression EXP Glafenine results in increased expression of DYNLT1 mRNA CTD PMID:24136188 NCBI chr 1:46,887,017...46,893,956
Ensembl chr 1:46,887,017...46,893,881 		JBrowse link
G Dynlt3 dynein light chain Tctex-type 3 decreases expression EXP Glafenine results in decreased expression of DYNLT3 mRNA CTD PMID:24136188 NCBI chr  X:13,327,933...13,337,139
Ensembl chr  X:13,327,892...13,337,139 		JBrowse link
G Dyrk2 dual specificity tyrosine phosphorylation regulated kinase 2 decreases expression EXP Glafenine results in decreased expression of DYRK2 mRNA CTD PMID:24136188 NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106 		JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 increases expression EXP Glafenine results in increased expression of EBNA1BP2 mRNA CTD PMID:24136188 NCBI chr 5:132,148,164...132,152,730
Ensembl chr 5:132,148,143...132,153,267 		JBrowse link
G Echdc3 enoyl CoA hydratase domain containing 3 decreases expression EXP Glafenine results in decreased expression of ECHDC3 mRNA CTD PMID:24136188 NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516 		JBrowse link
G Eci2 enoyl-CoA delta isomerase 2 decreases expression EXP Glafenine results in decreased expression of ECI2 mRNA CTD PMID:24136188 NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781 		JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 increases expression EXP Glafenine results in increased expression of EDEM1 mRNA CTD PMID:24136188 NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717 		JBrowse link
G Edem2 ER degradation enhancing alpha-mannosidase like protein 2 increases expression EXP Glafenine results in increased expression of EDEM2 mRNA CTD PMID:24136188 NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485 		JBrowse link
G Eef1b2 eukaryotic translation elongation factor 1 beta 2 increases expression EXP Glafenine results in increased expression of EEF1B2 mRNA CTD PMID:24136188 NCBI chr 9:64,580,163...64,582,737
Ensembl chr 9:64,579,893...64,582,737 		JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma increases expression EXP Glafenine results in increased expression of EEF1G mRNA CTD PMID:24136188 NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382 		JBrowse link
G Eepd1 endonuclease/exonuclease/phosphatase family domain containing 1 decreases expression EXP Glafenine results in decreased expression of EEPD1 mRNA CTD PMID:24136188 NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340 		JBrowse link
G Efr3a EFR3 homolog A decreases expression EXP Glafenine results in decreased expression of EFR3A mRNA CTD PMID:24136188 NCBI chr 7:97,552,677...97,633,369
Ensembl chr 7:97,552,677...97,633,369 		JBrowse link
G Egf epidermal growth factor decreases expression EXP Glafenine results in decreased expression of EGF mRNA CTD PMID:24136188 NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064 		JBrowse link
G Egfl7 EGF-like-domain, multiple 7 increases expression EXP Glafenine results in increased expression of EGFL7 mRNA CTD PMID:24136188 NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879 		JBrowse link
G Egfr epidermal growth factor receptor decreases expression EXP Glafenine results in decreased expression of EGFR mRNA CTD PMID:24136188 NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase decreases expression EXP Glafenine results in decreased expression of EHHADH mRNA CTD PMID:24136188 NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188 		JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein decreases expression EXP Glafenine results in decreased expression of EI24 mRNA CTD PMID:24136188 NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571 		JBrowse link
G Eif1ad eukaryotic translation initiation factor 1A domain containing increases expression EXP Glafenine results in increased expression of EIF1AD mRNA CTD PMID:24136188 NCBI chr 1:202,674,362...202,679,662
Ensembl chr 1:202,674,185...202,679,658 		JBrowse link
G Eif2ak1 eukaryotic translation initiation factor 2 alpha kinase 1 decreases expression EXP Glafenine results in decreased expression of EIF2AK1 mRNA CTD PMID:24136188 NCBI chr12:10,710,771...10,744,597
Ensembl chr12:10,705,874...10,744,573 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases expression EXP Glafenine results in increased expression of EIF2S1 mRNA CTD PMID:24136188 NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225 		JBrowse link
G Eif2s3 eukaryotic translation initiation factor 2 subunit gamma decreases expression EXP Glafenine results in decreased expression of EIF2S3X mRNA CTD PMID:24136188 NCBI chr  X:58,916,513...58,939,923
Ensembl chr  X:58,917,490...58,940,686 		JBrowse link
G Eif3b eukaryotic translation initiation factor 3, subunit B increases expression EXP Glafenine results in increased expression of EIF3B mRNA CTD PMID:24136188 NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886 		JBrowse link
G Eif3i eukaryotic translation initiation factor 3, subunit I increases expression EXP Glafenine results in increased expression of EIF3I mRNA CTD PMID:24136188 NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676 		JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 increases expression EXP Glafenine results in increased expression of EIF4A1 mRNA CTD PMID:24136188 NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858 		JBrowse link
G Eif4a2 eukaryotic translation initiation factor 4A2 decreases expression EXP Glafenine results in decreased expression of EIF4A2 mRNA CTD PMID:24136188 NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B decreases expression EXP Glafenine results in decreased expression of EIF4B mRNA CTD PMID:24136188 NCBI chr 7:133,206,637...133,228,436 JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 increases expression EXP Glafenine results in increased expression of EIF4G1 mRNA CTD PMID:24136188 NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941 		JBrowse link
G Eif5a eukaryotic translation initiation factor 5A increases expression EXP Glafenine results in increased expression of EIF5A mRNA CTD PMID:24136188 NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656 		JBrowse link
G Eif6 eukaryotic translation initiation factor 6 increases expression EXP Glafenine results in increased expression of EIF6 mRNA CTD PMID:24136188 NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401 		JBrowse link
G Eipr1 EARP complex and GARP complex interacting protein 1 increases expression EXP Glafenine results in increased expression of EIPR1 mRNA CTD PMID:24136188 NCBI chr 6:45,388,451...45,502,089
Ensembl chr 6:45,388,376...45,502,083 		JBrowse link
G Ell3 elongation factor for RNA polymerase II 3 increases expression EXP Glafenine results in increased expression of ELL3 mRNA CTD PMID:24136188 NCBI chr 3:108,413,035...108,417,181
Ensembl chr 3:108,410,448...108,417,132 		JBrowse link
G Elob elongin B increases expression EXP Glafenine results in increased expression of ELOB mRNA CTD PMID:24136188 NCBI chr10:12,848,830...12,853,897
Ensembl chr10:12,848,827...12,853,635 		JBrowse link
G Elof1 elongation factor 1 increases expression EXP Glafenine results in increased expression of ELOF1 mRNA CTD PMID:24136188 NCBI chr 8:20,645,336...20,650,888
Ensembl chr 8:20,645,336...20,650,579 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression EXP Glafenine results in increased expression of ELOVL6 mRNA CTD PMID:24136188 NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186 		JBrowse link
G Emc6 ER membrane protein complex subunit 6 increases expression EXP Glafenine results in increased expression of EMC6 mRNA CTD PMID:24136188 NCBI chr10:57,794,072...57,795,671
Ensembl chr10:57,793,685...57,796,217 		JBrowse link
G Emilin1 elastin microfibril interfacer 1 increases expression EXP Glafenine results in increased expression of EMILIN1 mRNA CTD PMID:24136188 NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698 		JBrowse link
G Enc1 ectodermal-neural cortex 1 increases expression EXP Glafenine results in increased expression of ENC1 mRNA CTD PMID:24136188 NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713 		JBrowse link
G Eng endoglin increases expression EXP Glafenine results in increased expression of ENG mRNA CTD PMID:24136188 NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230 		JBrowse link
G Enpep glutamyl aminopeptidase decreases expression EXP Glafenine results in decreased expression of ENPEP mRNA CTD PMID:24136188 NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression EXP Glafenine results in decreased expression of ENPP2 mRNA CTD PMID:24136188 NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827 		JBrowse link
G Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 decreases expression EXP Glafenine results in decreased expression of ENPP3 mRNA CTD PMID:24136188 NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041 		JBrowse link
G Eola2 endothelium and lymphocyte associated ASCH domain 2 increases expression EXP Glafenine results in increased expression of EOLA2 mRNA CTD PMID:24136188 NCBI chr  X:149,064,015...149,068,627
Ensembl chr  X:149,064,041...149,068,627 		JBrowse link
G Ephx1 epoxide hydrolase 1 decreases expression EXP Glafenine results in decreased expression of EPHX1 mRNA CTD PMID:24136188 NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235 		JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 increases expression EXP Glafenine results in increased expression of EPRS1 mRNA CTD PMID:24136188 NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966 		JBrowse link
G Eps8l2 EPS8-like 2 decreases expression EXP Glafenine results in decreased expression of EPS8L2 mRNA CTD PMID:24136188 NCBI chr 1:196,446,260...196,471,544
Ensembl chr 1:196,446,287...196,471,541 		JBrowse link
G Erg28 ergosterol biosynthesis 28 homolog increases expression EXP Glafenine results in increased expression of ERG28 mRNA CTD PMID:24136188 NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078 		JBrowse link
G Erh ERH, mRNA splicing and mitosis factor increases expression EXP Glafenine results in increased expression of ERH mRNA CTD PMID:24136188 NCBI chr 6:100,280,933...100,291,200
Ensembl chr 6:100,280,930...100,291,210 		JBrowse link
G Erp29 endoplasmic reticulum protein 29 increases expression EXP Glafenine results in increased expression of ERP29 mRNA CTD PMID:24136188 NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376 		JBrowse link
G Erp44 endoplasmic reticulum protein 44 increases expression EXP Glafenine results in increased expression of ERP44 mRNA CTD PMID:24136188 NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761 		JBrowse link
G Esam endothelial cell adhesion molecule increases expression EXP Glafenine results in increased expression of ESAM mRNA CTD PMID:24136188 NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215 		JBrowse link
G Etfdh electron transfer flavoprotein dehydrogenase decreases expression EXP Glafenine results in decreased expression of ETFDH mRNA CTD PMID:24136188 NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745 		JBrowse link
G Ethe1 ETHE1, persulfide dioxygenase decreases expression EXP Glafenine results in decreased expression of ETHE1 mRNA CTD PMID:24136188 NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052 		JBrowse link
G Faah fatty acid amide hydrolase decreases expression EXP Glafenine results in decreased expression of FAAH mRNA CTD PMID:24136188 NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677 		JBrowse link
G Fabp4 fatty acid binding protein 4 increases expression EXP Glafenine results in increased expression of FABP4 mRNA CTD PMID:24136188 NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578 		JBrowse link
G Fabp5 fatty acid binding protein 5 increases expression EXP Glafenine results in increased expression of FABP5 mRNA CTD PMID:24136188 NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773 		JBrowse link
G Fads1 fatty acid desaturase 1 decreases expression EXP Glafenine results in decreased expression of FADS1 mRNA CTD PMID:24136188 NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734 		JBrowse link
G Fads2 fatty acid desaturase 2 decreases expression EXP Glafenine results in decreased expression of FADS2 mRNA CTD PMID:24136188 NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789 		JBrowse link
G Fahd2a fumarylacetoacetate hydrolase domain containing 2A decreases expression EXP Glafenine results in decreased expression of FAHD2A mRNA CTD PMID:24136188 NCBI chr 3:114,657,176...114,665,349
Ensembl chr 3:114,655,865...114,665,356 		JBrowse link
G Fam114a1 family with sequence similarity 114, member A1 increases expression EXP Glafenine results in increased expression of FAM114A1 mRNA CTD PMID:24136188 NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174 		JBrowse link
G Fam117b family with sequence similarity 117, member B decreases expression EXP Glafenine results in decreased expression of FAM117B mRNA CTD PMID:24136188 NCBI chr 9:61,340,284...61,418,531
Ensembl chr 9:61,340,249...61,408,483 		JBrowse link
G Fam167b family with sequence similarity 167, member B increases expression EXP Glafenine results in increased expression of FAM167B mRNA CTD PMID:24136188 NCBI chr 5:141,920,695...141,922,342
Ensembl chr 5:141,920,695...141,922,340 		JBrowse link
G Fam210a family with sequence similarity 210, member A decreases expression EXP Glafenine results in decreased expression of FAM210A mRNA CTD PMID:24136188 NCBI chr18:61,846,447...61,886,123
Ensembl chr18:61,852,907...61,886,171 		JBrowse link
G Fam210b family with sequence similarity 210, member B decreases expression EXP Glafenine results in decreased expression of FAM210B mRNA CTD PMID:24136188 NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397 		JBrowse link
G Fam241b family with sequence similarity 241 member B decreases expression EXP Glafenine results in decreased expression of FAM241B mRNA CTD PMID:24136188 NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
Ensembl chr 6:30,052,324...30,055,084 		JBrowse link
G Fam3c FAM3 metabolism regulating signaling molecule C increases expression EXP Glafenine results in increased expression of FAM3C mRNA CTD PMID:24136188 NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078 		JBrowse link
G Farsb phenylalanyl-tRNA synthetase subunit beta increases expression EXP Glafenine results in increased expression of FARSB mRNA CTD PMID:24136188 NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045 		JBrowse link
G Fasn fatty acid synthase increases expression EXP Glafenine results in increased expression of FASN mRNA CTD PMID:24136188 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261 		JBrowse link
G Fastk Fas-activated serine/threonine kinase increases expression EXP Glafenine results in increased expression of FASTK mRNA CTD PMID:24136188 NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430 		JBrowse link
G Fbl fibrillarin increases expression EXP Glafenine results in increased expression of FBL mRNA CTD PMID:24136188 NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932 		JBrowse link
G Fbxo3 F-box protein 3 decreases expression EXP Glafenine results in decreased expression of FBXO3 mRNA CTD PMID:24136188 NCBI chr 3:90,417,262...90,449,557
Ensembl chr 3:90,417,297...90,449,557 		JBrowse link
G Fbxo7 F-box protein 7 decreases expression EXP Glafenine results in decreased expression of FBXO7 mRNA CTD PMID:24136188 NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530 		JBrowse link
G Fcgr2b Fc gamma receptor 2B increases expression EXP Glafenine results in increased expression of FCGR2B mRNA CTD PMID:24136188 NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778 		JBrowse link
G Fchsd2 FCH and double SH3 domains 2 decreases expression EXP Glafenine results in decreased expression of FCHSD2 mRNA CTD PMID:24136188 NCBI chr 1:155,444,471...155,685,350
Ensembl chr 1:155,444,460...155,685,539 		JBrowse link
G Fdps farnesyl diphosphate synthase increases expression EXP Glafenine results in increased expression of FDPS mRNA CTD PMID:24136188 NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776 		JBrowse link
G Fdx1 ferredoxin 1 decreases expression EXP Glafenine results in decreased expression of FDX1 mRNA CTD PMID:24136188 NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414 		JBrowse link
G Fdxr ferredoxin reductase decreases expression EXP Glafenine results in decreased expression of FDXR mRNA CTD PMID:24136188 NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658 		JBrowse link
G Fech ferrochelatase decreases expression EXP Glafenine results in decreased expression of FECH mRNA CTD PMID:24136188 NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348 		JBrowse link
G Fermt2 FERM domain containing kindlin 2 decreases expression EXP Glafenine results in decreased expression of FERMT2 mRNA CTD PMID:24136188 NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811 		JBrowse link
G Fga fibrinogen alpha chain increases expression EXP Glafenine results in increased expression of FGA mRNA CTD PMID:24136188 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528 		JBrowse link
G Fgl1 fibrinogen-like 1 increases expression EXP Glafenine results in increased expression of FGL1 mRNA CTD PMID:24136188 NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093 		JBrowse link
G Fis1 fission, mitochondrial 1 increases expression EXP Glafenine results in increased expression of FIS1 mRNA CTD PMID:24136188 NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377 		JBrowse link
G Fitm2 fat storage-inducing transmembrane protein 2 decreases expression EXP Glafenine results in decreased expression of FITM2 mRNA CTD PMID:24136188 NCBI chr 3:152,141,346...152,147,858
Ensembl chr 3:152,141,346...152,147,858 		JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 increases expression EXP Glafenine results in increased expression of FKBP11 mRNA CTD PMID:24136188 NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 increases expression EXP Glafenine results in increased expression of FKBP5 mRNA CTD PMID:24136188 NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674 		JBrowse link
G Flad1 flavin adenine dinucleotide synthetase 1 increases expression EXP Glafenine results in increased expression of FLAD1 mRNA CTD PMID:24136188 NCBI chr 2:174,819,451...174,828,921
Ensembl chr 2:174,819,453...174,828,977 		JBrowse link
G Flcn folliculin decreases expression EXP Glafenine results in decreased expression of FLCN mRNA CTD PMID:24136188 NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769 		JBrowse link
G Flna filamin A increases expression EXP Glafenine results in increased expression of FLNA mRNA CTD PMID:24136188 NCBI chr  X:152,007,758...152,034,266
Ensembl chr  X:152,007,758...152,031,052 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 decreases expression EXP Glafenine results in decreased expression of FMO1 mRNA CTD PMID:24136188 NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 decreases expression EXP Glafenine results in decreased expression of FMO3 mRNA CTD PMID:24136188 NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028 		JBrowse link
G Fn1 fibronectin 1 increases expression EXP Glafenine results in increased expression of FN1 mRNA CTD PMID:24136188 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678 		JBrowse link
G Fn3krp fructosamine-3-kinase-related protein decreases expression EXP Glafenine results in decreased expression of FN3KRP mRNA CTD PMID:24136188 NCBI chr10:106,688,413...106,697,137
Ensembl chr10:106,688,439...106,697,134 		JBrowse link
G Fndc3b fibronectin type III domain containing 3B increases expression EXP Glafenine results in increased expression of FNDC3B mRNA CTD PMID:24136188 NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830 		JBrowse link
G Foxa2 forkhead box A2 decreases expression EXP Glafenine results in decreased expression of FOXA2 mRNA CTD PMID:24136188 NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326 		JBrowse link
G Foxa3 forkhead box A3 increases expression EXP Glafenine results in increased expression of FOXA3 mRNA CTD PMID:24136188 NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155 		JBrowse link
G Foxn3 forkhead box N3 decreases expression EXP Glafenine results in decreased expression of FOXN3 mRNA CTD PMID:24136188 NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401 		JBrowse link
G Fpgs folylpolyglutamate synthase increases expression EXP Glafenine results in increased expression of FPGS mRNA CTD PMID:24136188 NCBI chr 3:15,972,800...15,993,592
Ensembl chr 3:15,972,800...15,993,563 		JBrowse link
G Ftcd formimidoyltransferase cyclodeaminase decreases expression EXP Glafenine results in decreased expression of FTCD mRNA CTD PMID:24136188 NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735 		JBrowse link
G Ftsj3 FtsJ RNA 2'-O-methyltransferase 3 increases expression EXP Glafenine results in increased expression of FTSJ3 mRNA CTD PMID:24136188 NCBI chr10:91,180,945...91,187,389
Ensembl chr10:91,180,696...91,187,397 		JBrowse link
G Fuca2 alpha-L-fucosidase 2 decreases expression EXP Glafenine results in decreased expression of FUCA2 mRNA CTD PMID:24136188 NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776 		JBrowse link
G Fundc2 FUN14 domain containing 2 increases expression EXP Glafenine results in increased expression of FUNDC2 mRNA CTD PMID:24136188 NCBI chr18:128,473...138,232
Ensembl chr18:132,248...138,345 		JBrowse link
G Fus Fus RNA binding protein increases expression EXP Glafenine results in increased expression of FUS mRNA CTD PMID:24136188 NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414 		JBrowse link
G Fut8 fucosyltransferase 8 increases expression EXP Glafenine results in increased expression of FUT8 mRNA CTD PMID:24136188 NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677 		JBrowse link
G Fxr1 FMR1 autosomal homolog 1 decreases expression EXP Glafenine results in decreased expression of FXR1 mRNA CTD PMID:24136188 NCBI chr 2:116,884,167...116,937,590
Ensembl chr 2:116,884,248...116,937,590 		JBrowse link
G Fyco1 FYVE and coiled-coil domain autophagy adaptor 1 decreases expression EXP Glafenine results in decreased expression of FYCO1 mRNA CTD PMID:24136188 NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021 		JBrowse link
G Fzd8 frizzled class receptor 8 decreases expression EXP Glafenine results in decreased expression of FZD8 mRNA CTD PMID:24136188 NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression EXP Glafenine results in decreased expression of G6PC1 mRNA CTD PMID:24136188 NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase increases expression EXP Glafenine results in increased expression of G6PD mRNA CTD PMID:24136188 NCBI chr  X:152,201,081...152,220,863
Ensembl chr  X:152,201,098...152,220,801 		JBrowse link
G Gab1 GRB2-associated binding protein 1 decreases expression EXP Glafenine results in decreased expression of GAB1 mRNA CTD PMID:24136188 NCBI chr19:27,131,262...27,239,236
Ensembl chr19:27,131,262...27,239,236 		JBrowse link
G Gabarapl1 GABA type A receptor associated protein like 1 decreases expression EXP Glafenine results in decreased expression of GABARAPL1 mRNA CTD PMID:24136188 NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450 		JBrowse link
G Gabarapl2 GABA type A receptor associated protein like 2 decreases expression EXP Glafenine results in decreased expression of GABARAPL2 mRNA CTD PMID:24136188 NCBI chr19:39,910,572...39,921,408
Ensembl chr19:39,910,534...39,924,628 		JBrowse link
G Gale UDP-galactose-4-epimerase increases expression EXP Glafenine results in increased expression of GALE mRNA CTD PMID:24136188 NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388 		JBrowse link
G Galk2 galactokinase 2 decreases expression EXP Glafenine results in decreased expression of GALK2 mRNA CTD PMID:24136188 NCBI chr 3:113,110,057...113,243,014
Ensembl chr 3:113,110,030...113,233,306 		JBrowse link
G Galm galactose mutarotase decreases expression EXP Glafenine results in decreased expression of GALM mRNA CTD PMID:24136188 NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310 		JBrowse link
G Galnt11 polypeptide N-acetylgalactosaminyltransferase 11 decreases expression EXP Glafenine results in decreased expression of GALNT11 mRNA CTD PMID:24136188 NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression EXP Glafenine results in increased expression of GAPDH mRNA CTD PMID:24136188 NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235 		JBrowse link
G Gar1 GAR1 ribonucleoprotein increases expression EXP Glafenine results in increased expression of GAR1 mRNA CTD PMID:24136188 NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524 		JBrowse link
G Gas5 growth arrest specific 5 increases expression EXP Glafenine results in increased expression of GAS5 mRNA CTD PMID:24136188 NCBI chr13:73,303,611...73,306,932 JBrowse link
G Gas6 growth arrest specific 6 increases expression EXP Glafenine results in increased expression of GAS6 mRNA CTD PMID:24136188 NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904 		JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression EXP Glafenine results in decreased expression of GBE1 mRNA CTD PMID:24136188 NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210 		JBrowse link
G Gcdh glutaryl-CoA dehydrogenase decreases expression EXP Glafenine results in decreased expression of GCDH mRNA CTD PMID:24136188